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~HE TRE.ATMEl'\IT OF RHEIDf..ATIC FEVER 
- -
Rheumatic infection is a.n in:f'!lammato.ry oon(!.:ttion of 
fibrous tissue manifesting itself in lesions of the Joints 
. 
{polyarthritis); heart(card~tis)' musolee (va.gu.e :pains); eye 
. . 
structures '(iritis or iridooyelitis); kidijey (glomerulOtieph-
ritis}; nervous system '(ehorea}; and subout~neoua tis~ues 
. . . ("nodules). The lesion oonsists of t~e Aschoff bo.dy which lies 
in close relation to the adventitia of small arteries. 2. 26. 
-~-~he etiology has not been established as yet. Until 
such a time as the agent or factors bringing abottt this dis-
. . 
ease are definitelY' determined, there will,eontinue to he a 
!flooding o:r thi; literature with the.ories, techniques of 
handling patients end drugs which are purported to be speci-
fic and ourati~e. 
A large amount of work has been done in an attempt to 
overcome this wide•spread disease. Rowever, it is a problem 
worthy of far more study, especially when the appalling ~act 
is noted that there a~e two to three million children of 
school ag~ who are suffering from Rheumatia Heart Disease -
and every year brings attacks of aoute Rheumatic Fever to 
l?a.ooo additional children. 
The most important concept to have arisen from all 
the study of Rheumatic Fever is tha·t all patients with beta-
hemolytic streptoooacal infections are potential Idieu.mat;i.o , _. ... .- .. 
II 
I 
.. 
. -
Fever subjects., especially if there is a pveviou;s .or family 
history of the disease. 
Coburn believes that the inflammatory rea¢ion in the 
~ascular tissues is the result o~ a constitutional de~eQt in 
th& fatient whicn elicits an abnormal antibody r~sponse to the 
antisenic stimulus furnished by beta•hemJ:>lyti-c streptococoi. 
The purpose Df treatment is to suppress the inflammator.y 
reaction and thereby cut cardiac damage to a minimum~ l3 
~ . -
Since no method has been ~ound as y~t to suppress the elabo• 
ration o:f antigen by the bae~rial agent • and there is• no; way· 
of modifying the constitutional defect of the host; our only 
to·rm of specific treatment is an attempt at :prev-ention of 
;~r ~ 
; ' 
infection with beta•hemolyotio streptococci: sttpi>resaion of 
antibody formation; or prevention of the antibody-antigen 
; 
reaction. 
· An ideal·regime of treatment of Rheumatic Fever 
_,would bbe one whiilh aea omplished the following: 
1. Prevention of disabling heart disease by r.urbing 
the inflaxnmatory-like reaotions in vascular 
tissues following ~onoeyclio and sabolinioal 
types; and prevention of recurrent attacks in 
the polyoyolta type~ 
s~ Relief of s~bjective symptoms, auch as pain, 
tenderness, weakness and stiffn~sa~ 
a, R~lief of objective signsfsaah as heat, redness, 
swelling. and tachycardia. This woula also 
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i_. include a ~eduction in the erythrooy~e sedimen-
tation rate and a lowering o~ the white blood count. 
4. Pre~ention of psychic disturbances which accompany 
any chronic protracted illness. 34, 54• 66 
---
Tbese, then, are the problams in therapy* and sinoe 
·-there is no one method of treating the~e patients, we mnst -
~ttempt to obtain satisfactory results by a complete 
orchestration of the various measures Which have'proven to be 
mbst successful in clinical trials. 
Rheumatic Fever must be treLted in both its active 
and ita quiescent stages. The trea.tm~nt of eaoh stage is 
different and will be discussed separately. 
!. Stage of Activity 
A. BED REST. 
Tha)r is universal agreement eoneerning the impor-
tance of abso[ute bed rest in the therapy of acute Rheumatic 
Fever, The 1rst period may involve many weeks or months, but 
should contij'j'l.e as long a.a there is a slight ;fever, slightly 
elevated tillil,~e blood Qoll£'lt or increased $~dimentation rate .. 
66. 100 I • 
........ - \ 
. I 
If ,~$re have been ant cardiao £indings on physical 
e~amin~tion ~1·r eleotrooardiographio study. the patient should r be kept-in b d tor at least one month after the sedimentation rate has ret ~ned to no~al. ~hen salicylate therapy is 
o-
0 
0 
l 
being used, iJ. is important to keep the patient in bed after 
the salieylat. ~ are disoonti~ued untii Electrocardiogram~ 
sedimentation ~ate~ wnite blood count. pulse rate ana tempera-
1[ 
tu.re have bee ' normal for at least one week. 54 
-
Th&r i shottld be both mental and physical rest, which 
l 
shonld inaluru a limiting of activity, quiet surroundinge 
' 
conducive to 'leap, and. diveraiona.ry- :facilities.. .M.tequate 
nursing care s important in promoting rest* sleep and 
mental diYers.on. 
1 
66, 34 
--
i 
B. Dim'f l' 
----. In t eating a case of acute Rheumatic veve~, the 
I 
If . diet should o~ontain at 'least 3500 calories par day., and it 
I' 
should be ea,lly digestible. Forcing fluids ia importa~t 
to rep~ace tlb loss via perspiration. 54, !§. 
Thejlbocurrenoe of rheumatic purpuras and increased 
capillary fr gility has lea to t~e use of large doses of 
vitamins in cute Rheumatic Fe~e~. Sendroy and Schultz 
I 
found no the apeutio benefit from administration o~ Vitamin o-
se~eral of t e ahildren who had reeeived adequate supplements 
o~ ascorbi~ aid for one to four months developed recurrences 
of Rheumatic :Fever. 10 Kuttner noted that several children 
f -
who had been given large doses of Vitamins A, B complex. c and 
I • 
D dev~loped ecurrencea. 43 Griffith found that Vitamin c 
did not causf a more rapi~c~nvalescence. Vitamin KanA 
Calcium in 1 rge dosages did not correct the increased 
/ 
0 
0· 
0 
capillary fr lgility. 34 
-
40 and Taran and Jacoba 87 feel that Vitamin 
-
C is importan in reducing the hemorrhagie manifestations 
of rheumatic je~er~ ~ith intelligent use of Vitamin 0, the 
incidence of pistaxis has been cut down to a minimum. 
Rine rt reported on the ase of Crude Resperidin-
(Vitamin P}. Although little is definitely known about 
thisttper.meability £actor"• there is increasing support for its 
ro1e as a nut itive factor essential in maintaining normal 
capillary str~ngth and ~~eability. Since most allergic 
reactions proltably involve the capillary bed, a. deficiency 
~ ~ 
in this tacto[y might re~d~~ the capillaries and adjacent 
tissues more ulnerable to such a reaqtion(brought on by the 
antigenic st~ulua of beta-hemolytic streptoooco1.} rn 19 
oases ~~te4 in the acute phase of ~heumatic Fever, all but 
one showed a 1 low1ng o% the sed1mentat1on·rate within one to 
three weeks1 lna tne clinical improvement parallele~ ~he 
"' 1
'1 
slowing eedi~1entation rate. 2'en oi' these oase~ ha.d been 
snowtag persJJrtnent rhQumatio aotivtty ror an average of 9,4 
weeks before jtharapy with V-itamin P was instituted, In most 
oases the seCIJ.!i.menta tion rate fell to normal in one to two 
I! , mon~hs. Two patients were studied for only one month and the 
I process remaj.ned active at the en<1 of tne· month.. .Four others 
showe~ trans,ent episodes of reactivation. mhis series is 
not large en ugh to enable any definite claims to be macJ.e. 
:Che reooveri this case may be instances of the 
0 
·o 
0 
' spontaneous r~covery which may be seen in pa»1ents with active 
Bheums.tic Fev lr., .t)51. Gx-i:f.fith reports that Vitamin P is of 
..... -
no use in ~he 1 treatment of Rheumatic purpuras. ~. 
Anemla ma~ develop secondary to the active rheumatic 
t 
state. This y be success£ully treated with 360 mgm (& grains) 
I 
of Ferrous su fate. t .. i.d. 34. 
-
the use ofJbpeeial dietary measur~s as I Ther 'fore; 
. . 
therapeutic a~ds in Rheumatic Fever patients is of limited 
l . 
value and eon~raversial. More important than this is the I . 
role o£ ~ault, diet as a factor of conditioning which in~ 
I ! . • 
creases the a~soeptibil~ty of the host to rheumatic fever. 
This subJeet ;ill be more completely discussed in relation to 
I 
prevention ~~~the disease. 
I 
a. DRUG TR~ lrY ..;;..;..:.~..-..-.~~~ 
I 
1. Su.lfon'mides. 
I • 
i ~he ssoaiation of Rheumatic Fever with hemolytic 
streptoooecusiinfeotions 1ed to a study of the effect of 
sulfonamide t. rerapy in acute Rheumatic Fever,.. 
Mass 1ll and Jones ·~ound that in none of their 53 
I ; 
patients trea~ed with sulfanilamide was there any symptomatic 
I 
relief or sho tening of the illness. In at least four of the 
I 
. ' 
cases, the dr 1 g seemed to increase the severity of the disease. 
I 
I ~here was an 'bnormally high incidenee of uoxio reactions, 53%~··~ 
t 
o1" the deve2oping rash or fever, ~his figure is 
0 
considerably higher than the peroenuage ox ~ebrile reactions 
. 
(16%~ and rashes (6%) developing in patients being treated 
wiuh sulranilami~e ror various other infections* ~hese 
reaotions may oe due to the a.evelopmen..t of a specific hyper- ~ 
sensitivity, since rspeated s.mall noses of,une drug may 
resu1t in the developmen~ ox to1eranoe to it. 50 
-Swift, Moen and Hirst also round that sy.mptoms of 
Bheumattc Fever were aggravated by the attministration Q~ 
sulfanilamide. In order to make sure tbat'adequate dosage 
~ 
was being attained, th~ nrng was given until gastric symptoms 
began to a);>pear. 86 ':fN.M-e.JJ- ana. 'o':eller x·eported toxic 
-
r~aotiona with high rever ana. the precipitation ot oon~ 
c=) gestive he~rt railure rollowtng sulzonami~e ~herupy in ~cute 
aneum~tio Fever.. 28 
-
Rosannlum ~eels ~nat the drugs ~Y be,userul in uhe 
rivsu xew~~ays of an acute attack. mhis shoul~ ne follovred 
by salicylate tnerapy, ye~ aaequate studies ot this form of 
J:e~ have not been .rnaa.e. 6th !l-t-iffith et al. uhougn 
-
con~amning their use as a fo~ of treatment ot ao~te Bhe~atic 
Fever, suggest the use ot full ~oses ot aultauiaz1ne in the 
treatment of.interourrent inreetions auuh as tonsill~tis,. 
sinusitis or otitis media with positive beta-hemoly~ic 
streptoeooeus cultURea. 34. Numerous authors concur in the \ 
-
opinion that e~en if sulfonamides are given as a treatment 
> 
for hemolytic streptococcus infection of the throat before 
c=J symptoms of acute Rheumatic Fever appear, it furnishes no 
-
c=> protection aeainst the subsequent development of acute 
Rheumatic Fever after this sore throat _. 53, 86, 18f 17,51,74 
............... ._.... ......... ._ _.. 
0 
2. Penicillin • 
.... 
There was little hope that penicillin would be of 
therap~~tie value in the treatment of acute Rheumatic Fever 
because of the failure of the sulfonamides. 
Foster et al used 1,000,000 units of penicillin ad-
ministered over a period of five days; which is twice the dosage 
. ' 
ordinarily acceptable for usual forms of beta-hemolytic 
streptoeQocus infection.- In this s6riea of 38 oases,,l9 
patients showed no change; 1 improved-perhaps ~ spontaneotis 
recovery; and 18 showed increased severity whioh most in· 
veatigators felt was attributable to the penicillin therapy. 
However, throat cultu~es Which had been pO$itive for the beta-
hemolyt~o streptococous on admission all became negative 
during peniollin treatment. 27 • Gri£~ith et all reported 
- . 
that penicillin therapy had no demonstrable effect on l3 
patients. 34. Bantz et al observed in his 6 oases that 
-
penicillin may be harmful by aggravating the condition; 
nevertheless, it does remove Group A hemolytic st~eptococeua 
from the throat. This fact indicates that the p~esenoe of 
the beta-hemolytic streptococcus is not n~oessary for the 
continuing rheumatic process. The sevemolinioal course may 
~e due to a destruction of large numbers of beta-hemolytic 
streptoooeoi in the nasopharynx with a flooding o~ bacterial 
c=) products into the s~am. Therefore, the suggestion is made 
0 
0 
that penicillin treatment be tried after the patient is 
adequately protected by salicylates. 6l • 
-Two patients ware seen who developed typ~aa1 signs 
of acute Rheumatic Fever during the coarse of peniciLlin 
therapy for severe Group A hemolytic streptococci infections. 
}enicillin, like the aulfonamidesj e~erts no beneficial ef-
fect .in Rh~umatio Fever wh$n it is given after the· estab-
lishment of the hemolytic streptococcus infection. that seems 
' i 
to induce the disease. 61 
-
From all available evidence. we can fin~ not~ng to 
indicate that Penicillin and Sulfonamides are of any use at 
' all in the treatment o:f act'ive Rheumatic Fever. However, 
these druge are of considerable importance in the ~·evention 
Of recurrences, and will be discussed at greater length in 
«onsidering the treatment of the inactive phase of the disease. 
0. DRUGVTREBAfY { oont) _ ............................ 
useful drugs availab~e for the treatment of Rheumatie Fever. 
It is important to determine what phases of !heumatie infec-
tion are amenabl.e to this form of thex•apy; and to establish 
~ the limitations of drugs • 
. For many years, it ~s- fel.t that the· an'bi•rheu.rnatic 
activity o~ the salioylates was as specific as the anti-
c=> · malarial action of quinine. The effect on inflamed joints 
0 
0 
was most st.t•iiting. Ma.oLa.gan in 1881 :felt that sa~ioyiatee 
cured inflamed joints, and that the·pain and swelling dis-
appeared, .21;; This view was oorxooborated by Lees, in 1903, 
46~ and Clarke in 1906, 19.,• • and has persisted practioa111 
u.ncballenged; Sheldon reports that adequate doses of sali- ~ 
oylates curtailed the diaea.se, as shown by snbsidenca of 
inflamed Joints; 72; Goodman and Gillman rep~t that 
-
salicylat~s completely relieve symptoms and signs of in~ 
flamed rheumatic joints in 80% of the cases, and failure occurs 
only in 1 to 2 % ot the w tients~ 32 Ta~an and. Jacobs feel 
-
that iarge doses o~ salioyla. tes effect a prompt subsidence· o:e·· 
all evidence of rheumatic activity in children with rheu-
matic polyarthritis. 87~ However, Griffith et al report 
. -
that there is·little effect seen when the drugs are use~ in 
f, 
the second or third cycles of the polyoyolio type, or in 
p~olonged monocyolip oases. !!• Batt, et al, working with 
ove~ -lOO ~atien~s with polyoyolio Rheumatio Feve~. fo~d that 
" I 
salicylate therapy does not prevent recurr~nces ani does not 
alleviate their symptoms in any but the ~irst atta~~~ 8 • 
-
White ±'eels that the salioylates are helpful in relieV'ing 
Joint discomfort and etf~sions into Joints and elsewhere 
into sa~ous cavities, 100. 
was not 
joints. 
-· Murphy telt that the effect of relieving joint pains 
indicative of a regression of the lesiQnlin th~ 
'i'"i< 
Therefore, he recentlY made an objective stndy o~ 
~· the size and temp~rature of Joints in l2·patients being -
0 treated with salioylates. Even though relief' of pain oc-
c~red with the usual promptness, there was no improvement 
in the measured size or temperature of the affected ~pints. 
Several of the p~tients developed oharaoteristic ~heumatic 
. {' 
~esions elsewhere in the body during the course of salicylate 
therapy (a;'e:- lungs, heart; solera.)58.. This series o:f cases 
'" -"t' 
is small and therefore it is difficult to draw valid con• 
elusions from the work- but it does indicate that the long 
r.!:•, IJ[' )' 
rf• 
accepted view that salicylates promote subsidence of r~eu- ~ 
matio joint inflammation may contain in it an element of 
wishful-thinking. 
The early worker.s with salicylates felt that adequate 
doses would prevent the de~elopment of cardiac complications 
or curtail the duration and extent of damage of an e~isting 
carditis. 51, 10. Taran & Jacobs recently reported s~ccess~ 
--
ful sappression of rheumatic activity in acute rheumatic 
oaFditis with the use of massive doses of saliaylat$S early 
in the disease. They were able to stop the progression of 
the cardiac damage, especially when the carditis was treated 
at its onset. They also feel that the percentage of re-
covery in patients Who are treated with salicylates lat~ in 
the disease is significantly higher than the recovery .rate 
of those patient~ who are treated only with bed rest and 
symptomatic therapeutic measures. It is impo~tant to give 
all such patients adequate doses orally, since i~travonous 
therapy is contraindicated. 87. Coburn noted that none of 
. -
0 his 38 :patients treated with adt:}qu.ate doses of salioyl~te, 
either oral or intravenous. developed valvular heart disease 
in a two ynar period of observation. On the other hand, J./3 
of tho 63 similar cases who were t~eated with small doses 
.o 
... 
deyelo~ed heart disease. 
Most investigators nov feel that the progress of 
the disaase process is not modified by salicylate therapy; 
and t'~at these dru.gs do not effect the development of eardiao 
complications, nor are they of valu.e·in treating carditie• 
~. ,§!. !i• 100 ~ .2.!,. Keith & Ross found that 10% of 
t 
Rheumat~l Fev$r patients uho entered with normal heart 
developed rheumatic heart disease, regardless of whether 
they were treated ~ith salicylates or not. 42• 
-~he antipyretic effect of salicylates is well known; 
its action in Rheumatic rever patients is identical wit~ its 
action in any febrile patient. There is not only a rapid 
., 
"' and~effeetive decrease in body temperature, but there is a 
\'conc~om:m1 tant decrease in pulse rate. li~~ 10~ !§_, .2,2., 34, .!2.2.• 
Ros~nbl~$feels that the sali~ylates have AO favor• 
~ , 
able effect on rheumatio nodules •. chorea. or akin rashes • .§§..~ 
Mode of Aot.ton ;;;;;.;o..-..-.._ ....................... 
fhe res~lts obtained with Salicylate ther~py natu-
rally lead us to a consideration of the mode of action of 
these drttgs. Are they merely analgesio and antipy~etio:·or 
0 is there a t~ue ant.i-inflammatory action which is specific 
<:) · for rheumatic infection? This question is diffienlt to 
answer in view of the unknown etiology of the disease. 
0 
0 
The possibility o~ an allergic phenomenon being 
responsible £or rheumatic infection was advanced by Boots 
& Swift, who demonatrated that the synovial exudate from 
affected ~oints ot patients suffering from serum sickness 
is indistinguishable mifcroseopioally fran that occurring 
in Joints of patients with Rhewmatic Fever. 7. Rio~ and 
-
Gregory have been able to produce lesions resembling 
rheumatic carditis; arthritis and pneumonitis·in rabbits 
subJected to experimental serum siolness. 62, 63. 64. This 
---
work hac lad to the investigati·on of the possible role of 
salicylates in suppressing antibody formation or·preventir~ 
the antibody-antigen reaction. 
Coburn ~ Kapp showed by immunological studies in 
vitro that sodiwm salicylate modi~ies the precipitation of 
normal rabbit serum ~lobulin ~Y its antiserum. They also 
showed that when sOdium salicylate is added to a system 
ao~taining egg albumin and its antibody, precipitate £orma-
tion is partly inhibited, the degree of inhibition ~epending 
' 
upon"the salicylate concentration. The ~f~eot on immune 
precipitate was reversible and appear to be due to inacti• 
vation Of antibody. Salicylate appears to b.@ more effective 
in preventing speoi~io preci tation than are the other anions 
ot the lyottopic s·""ries such as thiocyanate and iodide. 16. 
-
This same effect has not been established in ~ivo. However. 
.....-- ;._ "t.'::.v-;--
.>tc- ... ...,...-=.. '-~ 
Q the results indicate that the salioylates may aot by pre-
venting the preciptation o~ antigen by antibody. 
Swift found that when rabbits were treated with 
sodium salicylate and at the same time were immunized with 
intravenous injectious of streptococcus veridans and washed 
sheep erythrocytes. there was diminished complement-fixing 
antibOd.ies. agglutinins and hemolysins as compared VJith 
controls ~hioh were not treated with salicylate bnt were 
. 
similarly immunized. ·He was also able to show that v1hen 
~ ~ 
antigins are t~e·~·~ith sodium salicylate in ~itro and __ 
' ~- ~ 
then inJeote~ ~travenously into rabbits, the animals 
• I 
show a lower antibody titre than did rabbits receiving the 
untreated antigen intravenously. 63. Derrick et al 
-() administered acetysal1oylio acid to patients who had received 
0 
. 
large amounts of antipneumoooccus horse serwm. They found 
that they did not develop a rise in titre of. anti-horse 
serum preoipitins, and did not develop the arthritis of serum 
sickness~ &.2• These results indieate that salicylate~ 
may suppress antibody formation. 
Derrick et al found that the drugs did not prevent 
the development of urticaria, ~hioh was more intense in 
cases treated ~ith salioylates. This seems to indicate 
that the drugs did not actually snppress antibody formation 
or prevent reaction between antigen and antibody. 25. Sable 
-
feels that salicylates have no effect on immune responses. 67. 
-
It has been suggested that the salieylates may be 
effective in Rheumatic Fever by virtue of its action as a 
~ bacterial inhibitor. This inhibition may be either non-
specific by its aotion as a protein denaturant;' or may be 
specific by means o~ inhibition of certain enzyme systems. 
67; Lutwak Mann has shown that the salicylate' e~ert pro-
- ~ 
0 
0 
found changes in metabolism and effects several as yet 
unidenti~ied enzyme processes. ~· However. in view of the 
fact that the potent su1tonamides and penicillin have had 
little effect in influenoing the inteotion, there is little 
hope that the salioylates have any effect on the underlying 
infectious ag~t~ 
Liohtwitz suggests that the action of salicy~tes 
' 
and otber antipy~etic substances may be upon the initial 
edema which precedee the irreversible degeneratio:n. of tissne. 
.. 
Sinoe it is this degeneration which evoke~the defense 
' 
mechanism of inflammation, he feels that snppression of the 
edema may prevent development of inflammation. ~· 
The mechanism wherel>Y salicylates decrease 'body 
temperature, ls not olea~. Appar$ntiiY heat production is 
not inhibited. Reat dissipation is thought to be augu-
. '• 
"' mented by increase ot peripheral blood flow and sweating .. 
However; the elevated body temperature may be lowered, 
even if atrop'ine is given to prevent sweating. 58. 
-
0 
0 
0 
When considering the clinical aspects of salicylate 
therapy, it is necessary to understand the importance of 
determining pl~sma salicylate levels and.er1throc1te sedi-
mentation rate. The noncept of these two laboratory pro-
. . 
cedures as p~oposed by Oobur~ to relate to salicylate therapy 
of Rheumatic Fever have enabled us to develop rational 
techniques of treatment. Prior to Coburn's work, the sole 
method of det~r.mining whether a patient was getting adequate 
~ ., 
doses of drug or not ~as by watching for the development of 
. . 
early toxic symptoms. In 1943, Coburn by determing the plasma 
salicylate levels in his patients, reported that levels of 
350 gamma per co. or higher may be required to suppress the 
rheumatic inflammatory reaction (l gamma equals ~001 mg.) 13. 
~ 
Salicylate eoncentrations between 100·200 g~a/co. may re- · 
lieve all symptoms without ~uppressing the inflammation - and 
mat mask a prog~essive inflammatory reaction~ He founa that 
there seems to be an association between a £all• of the plasma 
level below 100 gamma/co. and renewed ~heumatia inflammation. 
The plasma salicylate concentration is controlled by. 
l) absorption. 2) deg~edation, 3) possible tissue localization, 
and 4) drng excretion. The suppression ?f the rheumatic 
in~lammatory reaction seems to parallel and be dependent up:n 
the oiroula~ing plasma salicylate concentration. The prompt 
suppression of this reaction may prevent t~e development of 
the cardiac complications of Rheumatic Favor~ 
0 
0 
. Therefore, during salicylate therapy, the plasma 
levels should be determined in order to see if the patient 
is aatua.lly taking the drug; or if the levels are those to. 
be expected u~th the amount of drug given; or i£ the level 
required for the patient's protection is being maintained. 
This will prevent failures in the occasional oases which 
may oxorete the drug rapidly. conjugate it abnormally. or 
fail to absorb it properly. ~· 
In addition ti plasma salicylate levelsJ.erytbrooyte 
sedimentation rates should be determined at frequent inter" 
vals. An increased sedimentation rate is not diagnostic of 
active· rhetullatio infection ... it indicates· the existence of a 
chronic dieeaoe,. and ·therefore may occur in Tuberculosis, 
Undulant Fever, Blood. Dysorasia.s and many others. !§..• 
However, Coburn feels that the sedimentation rate can be used 
as a reflection of the intensity of rheumatic inflammation 
in eon~unction with the clinical mahifesta.tions. Theref~te, 
it is used to study the effects of the salicylates~ A 
markedly elevated sedimentation rate cannot be expected to 
reach not~al within a week because the existing in~lammator.y 
reaction has already induced elaboration of serum globulins 
which are responsible ~or the inorea.s~d rete of sedimentation 
of red eells• If this sedimentation rate can be modified 
so that it stops rising after 72 hours of tr~atment, and then 
falls to nor.mal within 14 days, Ooburn believes that the 
<:> rheumatic re.ction will have been suppressed and fnrthe~ 
0 
0 
0 
cardiac damage inhibited. 13. 
-
Method of Administration ___ .......,..........,_........, ...... 
Three ~outes of administration of salioylates have 
/ 
bean investigated ••• oral, Intravenous, and Rectal. 
Reetal administration has been sugge~ted by swift as 
baing useful when oral therapy causes nausea. 120 to 180 co. 
/of 2% solution of sodium salio;rlate (lO grains I ouno~ of 
. 
~"water) two or three times dt\ily ma;r be used. A weak star~h 
solntion may be used as a vehiole if rectal irritation 
occurs •- 8th Goodman and Gilman state that salioyla tes are 
""'!'"'" 
readilY absorbed from the rectum. 32. However, G~iffith et 
-
a.l finds that there is poor absorption from the rectum and 
no appreciable amount reaches the blood str~am. ~· In 
addition~ Ma~tin has had difficulty obtaining the cooperation 
of many of the patients with the result that the medication 
is expelled. 52. Therefore, there seems to be little value 
-
in this method of a&miniatering salioylates. 
Oral administration is the simplest and most ef• 
feotive method according to most of the articles written-in 
recent yearD. However, there are several oontraversial 
points related to this form of therapy;-
Coburn finds that the administration of 10 grams 
. 
of Badium Salicylate daily will provide an average ptaama 
sali~~late level of 369 gamma/co. ~he drug is given in 
0 1 .• 6 gm. doses with ~6 gms. of sodium bicarbonate every :f'our 
hours day and night. Peak blood salicylate levels are· 
reached 48 hours after the treatment is instituted. 13 • 
0 
. -
Butt et al maintained adequate blood levels of 300 to 500 
gamma/ co .• with oral dosage o:f 6 .• 6-10 gms of sodium salicy-
late, using .6 gm. of sodium bicarbonate for every 1.6 
gm. of sodium salicylate. 8 • McEachern obtained adequate 
-
bloodlevels of 350-400 gamma/co with daily administration 
I 
of 10 gms. of sodium salicylate and 5 gms. of sodium bi-
carbonate. 54. 
. 
Keith and Ross bavG found that when 10-13.3 grams of 
f . 
sodium salicylate or aspirin are given in 5 daily doses with 
~qual amounts of sodium bicarbonate, the salicylate levels 
average 270 gammas/ca. with 10 gms. of sodium salicylate; 
and 310 gammas/co. with 13.3 grams of·sodium salicylate. 42. 
-
' 
These values for salicylate levels are lower than those which 
are generally considered ideal. 
Taran & Jacobs regulated their dosage according to 
the weight of the patient~ They administer l 1/2 grains 
per pound body weight daily, giving equal amounts of sodium 
salicylate and sodium bicarbonate. With this amount of 
drug {10 g~ams/ day in a 100 lb. patient) they are able to 
maintain ~lood levels of 300 to 450 gamma/co. 87. 
-
Griffith et al find that optimal blood levels of 300 
to 500 gamma/co. may be obthined using either sodium 
<:) salicylate or aspirin. Rowe~er, when using sodium salicylate 
<:J 1.6 grams should be used with .6 grams of sodium bicarbonate 
every four hours day and night. When ~spirin is used, 1 1/4 
grams shoudl be used with equal doses of sodinm bicarbonate • 
. " 
At least 3000 co, of water should be given with these drugs. 
If the bloo~ leyel is low, suspect that the ~atient is not 
taking the drug. If the lev~l is too high, the fluid intake 
is not high enough. 54. 
-
~he use of sodium bicarbpnate in conjunction with the 
salicylates has been one of the ma~y contraversial points in 
' 
recent literature pertaining to rhewnatic fever therapy,. 
Smull• Wegria and Leland, 76 have f~d that the plasma 
. -
salicylate levels are definitely lower when sodium bicar-
bonate ll.s given with sodium salicylate than when the ealicy- ~­
lates are given alone. They feel that this may be due to 
1) lleorea ... ed absorption of the drug from the gastrointestinal 
tract 2} increased extracellular fluid volume leading to a 
dilution ~f the plasma salicylate concentration; or 5) an 
increased renal excretion. This latter proba,blY a.~o ounts 
'j~ ~~ l. 
for it at least in partt,beoause patients who have~ 
received excess alkali have a slightly lower pH in their 
glomerular filtrate. This resultx in more unionized salicy-
. ' 
late, ~hioh may be more rapidly absorbed than are salicylate 
ions. There seems to be an increase in the apparent clear-
. . 
ance above a pH of 7.0 75 .. 
-
Coombs reports that sodium 
bicarbona_te administration will cause an increased excretion 
() not only of salicylatet but also of uulfonamides and Qrganic 
.· 
<:) ~Qids when given with these substan~es. 23. On the other 
hand Sable and Goodman & Gilman state that sodium bicarbonate 
has no effect on the excretion of salicyl in the urine. 
0 
67, 32~ 
--
lriffith et al report that lower doses of sodium 
bicarbonate will not lower the blood salicylate level. 
The purpose of administering sodium bicarbonate with the 
salicyiates is to prevent gastric irritation. The hydro-
chloric acid of the stomach changes the sodium salicylate 
and aspirin to salicy~ic acid, thereby increasing the total 
titrat.able acidity. 34, 67. Aspirin also is said to cause 
--
gastric retention. Sodium bicarbonate diminishes both these 
effects, and this is strong support for its use~ However. 
overdosage of salioylates(whioh will be discussed later) may 
lead to a respiratory al~losis - and sodium bicarbonate 
administration would aggravate, rather than alleviate this 
condition. 67. 
-
~egria & Smull, 97~ did uot usa sodium bicarbonate 
-in their series of eases because of this depression of the 
blood salioylate leveL. To combat gastric irritation, they 
· · used enteric coated capsules of sodium salicylate. A tnain-
te~noe dosage varying from .9 to l.S g~ams of the drug was 
used,.depending upon the weight of the patient. They were 
able to reach optimal levels of 350~500 gamma/co ~ithin the 
first 24 hours by oral administration of the drug(in doses 
.0 equal to twice ·the amount nssumed ta» be the maintenance dose) 
•' 
~ e~ery four hours for four doses. Maintenance doses were 
given eV'ery four hours day and night after this. 
r 
0 
Griffith et al, !!, feel that salioylates should 
na~er be given in thefor.m of enteric ooated capsules. Slow 
disintegration o~ the capsules in the iower bowel may give 
rise to the absprption of a toxic dose of the drug. 
"' Normally, absorption of the salioylat~s1~kes place 
" 
very rapidly in the upper G.I~ tract. ~he drug appears in 
the blood 15 to 30 minutes after oral administration, and 
peak plasma levels for the individual doses a~e obtained in 
about one hour. 34) 7a~ There is equally good absorption 
--
of most salicyl compounds. 67. However. it should be borne 
-
in mind that absorptionrof the d~g is slow in a patient 
~. ; 
with congestive failure, and such a patient is not ~terially 
benefited by oral salicylate therapy. 34, 
-
The excretion of salicylatea is ao rapid that the 
blood is eompletely free of the drug within 48 hours after 
treatment is s~opped. !1• .§2.• J{app and Coburn, g., found 
that in ~normal patients about 85% of the administered 
drug is excreted in the ~ine as salicy~ compounds. Of this, 
only 20% was ~rea salicylate, the rest being salioylurio acid 
and oonj~ted gl~curonates •. Therefo~e. 15%-20% of the 
administer~d salicrlate is destroyed in the body in normal 
patients. However, in patients ~ith rheumatic fever and 
certain other oonditions(such as tuberculosis, ~hronio a1co-
~ holism, and morphinism) there is apparently a destruction of 
<:) 30~40% of the administEred salicylate, since the amonnt ex~ 
oreted is only 60-70% of the amount administered. The dis~ 
ap~ea~ance is ~pparently due to more extensive modifio~tion 
of the salicylate in the bod1 and not to ~torage, since the 
deficits are not made up later. Patients showing good clini-
cal response to salicylates have .low outputs of the drug 
Q, 
0 
on~y for a few days. ~en remi~sion of the fever bas occurred, 
the amounts excreted again are within no:rmal range. 67,41,52 •. ,. • 
.:. ' ......_....._,_ 
Rheumatic patients also excrete 2•4 times as much in conJugated 
forms. Those patients who respond best clinically, excrete a 
larger pnnpmrtion in the form of free salicylate than those 
who heve not responded well. These findings suggested to 
Coburn the possibility that sane salicylic acid reacts with 
-the inflammatory process and is there.tore con~ugated~ This 
would be compatible with his theory that the effect of 
s~lieylates on rheumatic fever ~ep~nds on the concentration 
of circuLating salicyl radical.l3. However; ther~ is no 
-
selective distribution of the salicylates in pathological 
fluids t,o acc~unt for its therapeutic action. The concen-
tration of the drug is the same in the Joint fluids of a 
rheumatic ratient as it is in the patient's blood. There is 
no free sa.licylic acid r·I'esent in Joint fluid - or any body 
fluids or tissues. The pH necessary for liberation of the 
acid i~ lower than can occur in the tissues. Therefore; there 
is no basis to the theory that the therapeutic action of 
salicylates may be due to the antibacterial action of salicylic 
0 
0 
Intravenous salicylate therapy in rheumatic fever is 
by no means a recent development. It was first recommended 
by Mendel in 19041 ~·• and later used by Conner in 1914, 
Lesne 1 !l' and Gilbert et al in ~921, ~· It was Coburn, 
however, in 1943• ~. who .est.ab1.ished a rational techniqu.e 
of intravenous therapy based on his theory that cardiac 
damage may be inhibited by a prompt suppression of the 
rheumatic inflammatory reaction. Therefore, his purpose was 
to attain quickly high concentrations of circulating plasma 
salicylate and cause a rapid fall in the ~rythrocyte sedi-
mentation rate. He proposed the following method of t~e&t-
ment:- • 
First day - 10 grams of sodium saltcyla·te in 1000 cc. of _.9% 
salt solution adndniste~ed by intravenous drip over a 
period of 4 to 6 hours~ 
Second day • If the te~erature is not normal, or the s~ptoms 
> 
persist~ 20 grams of sodi~ salicylate in 2000 co. of 
.• 9% salt solution given by intraveous infusion over a 
period o£ 8 hours. If temperature is normal, continue 
the treatment of the first day. 
Third day - If the temperature is still not normal. or 
symptoma pers~st, the treatment of the seoond day is 
repeated. If the temperature is normal, repeat the 
first day treajment. 
0 
Fourth to Gixth day- Continue intravenous infusions until 
" -- ~ ;--a> ' the sedi~tation rate has dropped 20%, 
Seventh day- O~al treatment instituted. Continued until the 
30th day. Do not discontinue therapy w1til the 
, "' J ~ 
sedimentation rate has been normal for 2 weeks • 
• 
'2here are certain definite advantages to this form· 
of" therapy:- l) Plasma salioyla te levels of 400 garrtm.ta/ co. may 
be attained by intraven~us !~fusion ia only 4 hours, whereas 
it·would take 48 hours to ~each the same level with oral doses. 
Levels of 600 gamma/co. may be attained with few toxic 
reactions in a hours by intravenous administration'of 20 
grams of salicylate, ~; whereas it is difficult and im-
() practical to obtain such a high level with oral doses due to 
--~ 
0 
the severetoxic reactions which frequently ensue when levels 
above 500 gamma/a~. are r~ached. !2• 2) A known d'osage' 
can be administered to patients without the ~ea~ that some 
. . 
of the medication may not be absorbed. or may be lost by 
vomiting. 3) It is said to cause a rapid reduction of the 
acute symptoms. and may possibly curtail oardiaa complications. 
5~. ~~) S"$..v!'~u~-!dthor.s-tllaim iJha t~~ t.htf_.s!tdtr ttee.oti ons of 
. 
oral treatment such as gastric disturbances. are avoided by 
em:·'loying the intravenous route, .2§., !?.• ~' .2!• 
Wegria & Smull found that they could q~ickly reaoh 
optimal levels by intravenous administration of 7-10 g·r'ams of 
sodium salicylate dissolved in from 250-500 co, of normal 
' 
saline given·over a period of 1·2 ho~s every day for a f'e~ 
. 
1 
0 
·~ 
days. HOwever, the salicylate levels fell far below optimal 
values by the time of the next infusion. These. tluetuations 
are considered undesirable,97. Ooburn.himself noted a marked 
- -
-~ drop in the plasma salicylate level Within 12 hours, whereas 
' 
with oral therapyt ttie plasma levels remain fairly con~tant 
after' the second day of treatment. 13... McEachern also fou.nd · 
-
that the plasma level was below the ideal 350~400 gamma/qo. 
for at least 12 hours eacb day. In addition, the rapid ~iae 
in blood salicylate levels following intravenous therapy 
seemed to be poorly tolerated by the pahients; resulting in 
a higher inoidenoe of toXid reactions than was seen in orally 
treated patients, • .2!• Griifith et al,34• report that the 
() administration of 1000 oc~ of l% sodium salicylate intra-
venously over a period of 6 to 10 houra tires the patient 
and throws a load on the ~ight aide of the heart. IO co. 
of a 10% solution intravenously does no har.m when in3eoted 
through a 26 gauge needle at the rate of l ca/ min~te. 
However •. this solution may sclerose the veins, making ~urther 
admdnistration ~ery difficult~ 34. 
-
McEachern. 54, carried out a controlled experiment 
-
with 74 patients with rheumatic polyarthritis, hal~ of them 
. 
with adequate oral doses and the other half v.rith GobW?nSa 
method of intravenous therapy. An analysis of his figures 
give the following comparison between the two methods of 
treatment as regards the avorage length of time it took for 
the various signs and symptoms to retu:rn to .aormal:-
0 
0 
Temp. Pulse 
Intravenous 
Joints l·J.n ... o. Sed. Rate 
Treatment 3.1 d.· 4.8 d. 3 .. 1 d. 12.5 d. 18.4 d • 
. 
oral 
Treatment 1.9 d .. 3JI4 d. 2.4 d. a.a d. 18.3 d. 
Thus* according to these figures* oral therapy is 
more effective than intravenous therapy. 
Tar·an & Jacobs. in treating 14 patients .for .t'heu.-
matic polyarthritis, treated half orally and half intra-
venously, They found that the symptoms subsided promptly 
with both methods of treatment. However, the fall of the 
sedimentation rate to normal was delayed in the orally 
treated group to an average of 7 weeks, whereas the sedi-
mentation rat;e of those treated intravenously was normal 
in an average of 4 weeks. The recovery was complete in all 
these patients and no cardiac complicatioils deveJ.oped, These 
same authors, in treating cases of rheumatic cardicis, ob~ 
tained satisfactory results \Vi th oral therapy an~ were able 
to cause a fall in sedimentation rate to normal in an average 
of 9 weeks, as compared with untreated oases of carditis in 
whlch the sedimentation rate remained elevated for an average 
o:f 27 weeks.. On the other hand.; intravenous sodium salioy-
~~
late to patients with rheumatic carditis resulted in the 
develop~t of heart failure. The intravenous route in 
such patients is therefore hazardou.s and should not be 
• l 
used,- 87~ 
-
0 In retrospect, we can conclude that intravenous 
.. . . . 
therapy is of limited value in present-day treatment. Its 
t II ' ' • "' l • 
field of usefulness seems limited to oases whe~e nausea 
and vomiting exist,!, .~here is still oontraversy as to a 
possible more rapid effect on the reduction of the sedi-
mentation ra~e. Rowever, there are several reasons why 
most authors today have condemned intravenous salicylate 
therapy:• 
l. Fluetuating blood levels, with inadequate levels exist-
ing.~t least half of every day. 54. 
--' 2. Technical difficulties associated with prolonged intra-
venous infusions. 87. 
-
() 3~ Possibility of inducing heart failure in a patient with 
carditis due to the increased load on the right heart· 
brought about by large amounts of fluid a~inistered 
intravenously. · 
4. Rapid and complete absorption of the salioylates from 
the gastrointestinal tract make the intravenous ad-
ministration unnecessary. 
5. Relief of symptoms in many oases is more rapid follO\'"Iing 
oral doses than intravenous treatment. 54. 
-
6. The failure of tolerance of a rapid rise in blood sali• 
cylate levels may lead to the development of many more 
toxic symptoms than would. be obtained by Qral adminis-
tration. These toxic symptoms are discussed mo~e fully 
i~ suQsequent pages of this paper. 
0 
0 
Salicylate therapy should be continued for two to 
four weeks after the sedimentation rate has fallen to normal. 
l!' ~· If there have been any cardiac findings, either on 
electrocardiogram or physical examination. the salicylate 
therapy should continue for at least one month, followed by 
. 
another month of bed rest. 54. 
. -
Wegria & Smull in treating 21 patients with enteric 
coated oapsnles of sodium salicylate and comparing them with 
19 controls, ~ound that adequate salicylate therapy did not 
shorten the attack unless therapy was instituted within a 
week of ons0t of symptoms, 98. 
-
Toxicity 
The large ther§peutio doses of sal~oylates which are 
used for rhettmatio fever border on the toxic dosage of th~ 
drugs. Goodman & Gilman state that 10 to 30 grams of 
salicylate ingested at one time has caused death. On the 
other hand, there have been oases reported of recovery after 
' 
the ingestion of up to 65 grams of the drug. 32. 
-
I~ employing salicylate therapy, it is necessary to 
bo fully acquainted with the many toxic manifestations of 
these drugs. However, Sable feels that m~ny men use in-
adeqqate doses because they stop therapy at the first sign 
o~ toxicity. Re reported on 33 patients treated with doses 
varying-fr~ 8.,3 to 16 grams of salicylate per day. Most o~ 
these developed signs of toxicity early in the course of 
0 
therapy, bnt 72% of the cases were s,y.mptom free in the later 
stages of the disease. Therefore, in many instances it may 
~e no~~ssary to overlook early toxic symptoms in order to 
attain effective blood salicylate levels. 67. By studying 
-
the toxic effects of salicylates we may learn to distinguish 
between those symptoms wh~oh are to be expected, and those 
which demand immediate cessation of therapy. 
The commonest symptoms encountered when therapeutic 
doses of salicylates are administered are:~ 
1} Headache 
2) Nausea 
3) Vomiting 
4) Dizziness 
5) Tinnitus 
6} Par~ial Deafness. 
Other manifestations of toxicity which have appeared 
<:) less commonly are:-
0 
Weakness 
Drowziness 
-Anorexia 
Chills 
Profuse Perspiration 
Flushed facies 
Hyperpyrexia 
Thirst 
Burning of the eyes 
"Heartburn" 
Hematemesis 
Diarrhea 
Elefated. BMR 
Jlaohycerdia 
Hyperpnea & Tachypnea 
Disturbances of Acid-Base . 
Balance 
Fall in blood pressure 
Delirium 
Oe~ebral Excitement 
Hallucinations 
Aphonia 
Anemia 
Granulocytopenia 
Hy,poooagulapility of blood 
Renal involvement 
Liver involvement 
Allergic manifestations 
Several of the more important results of salicylate 
intoxication are ·worthy of closer consideration •. 
Nausea & Vomities:-
Many authors have reported clinical evidence of nausea 
and vomiting following therapeutia doses of salioylates~ 34,~. 
0 It has been shown that oral doses of salicylates cause 
~rri~ation of the gastric mucosa~ Gastroscopic examination 
:eveals that when the drug comes in contact with the mucosa, 
. 
a hyperemia followed by extravasation of blood occurs. This 
acicounts for.the cases of Hematemesis that have been reported. 
67. The use of sodium bicarbonate to alleviate this irri-
-
tation has already been discussed. Kieth & Ross found that 
even with bicarbonate administration, nausea. and vomiting 
are very eommon early in the course of treatment. However• 
they feel that this is not sufficient cause for st~~ping 
salicylate the~apy;'Sinoe these symptoms usually ·disappear 
within a few days. ~ The use of enteric coated capsules 
() by Wegria & Smull in 21 cases resulted in a ~ew instances 
~-
I 
of nausBa~ but eliminated vomiting almost entirely, as long 
as the blood salicylate level remained below 500 gamma/ca. 
Ooburn was able to administer 20 grams of salicylate in a 
hours intravenously without any untoward symptoms except 
mild tinnitus. whereas he was unab1e to increase oral dosage 
above 10 grams ter day without bring on gastrointestinal 
irritation with nausea and vomiting. Y• However• Mc:machern 1s 
studies have shovr.n that the rapid rise in blood salicylate 
level produced by intra•renous administration is poorly toler-
ated by many patients, and nausea and vomiting are common in 
these patients; 54; The dose required to produce vomiting by 
-intravenous therapy is smaller than the dose required by the 
0 oral route, indicating that the gastri'o symptoms may be du.e 
·0 
to a central emetic e£feots in addition to a local irritating 
action •. 67. 
-
Tinnitus 
~innitus is so commonly encountered in saliotiate 
therapy that before the method for determining blood salicy-
late level was established• this symptom was one of the 
criteria used by clinicians to ad~ttst the dosage. It is more 
commonly encountered early in the administration of salicrlates 
than after the patient has been receiving the drng for several 
days* 42. Griffith et al find tinnitus and all other 
-
symptoms ra~e when therapeutic doses are given with sodium 
bieerbollate and large amounts of watert !!..• McEachern 
() reports mild tinnitus in 25% of patients treated with oral 
doses. However. it is much more oommon·in patients treated 
by the intravenous method. 54. This is corroborated by 
-
Taran & Jacobs who reported severe tinnitus in all patients 
in whom blood levels had be.en raised to 390o!o450 gamma/ oo .. 
by intravenous route, whereas the same 1evels1 when r$ached 
orally did not cause tinnitus. 87. ~egria & Smull report 
-
that tinnitus appeared in their »attents usually by the time 
the blood salicylate level had reached 200 gamma/eo. after 
oral therapy. As higher levels of salicylates were attained, 
the tinnitus was replaced by d~afness, wbioh always dis· 
appea~ed within 24 to 48 ho~s after salicylate therapy was 
discontinued~ Blood levels above 500 gamma/co. ga~e rise 
to intermittent auditory end visual hallucinations. 98. 
-
0 
~he deafness hae been found. to be a sub~eotive- complaint, 
and there seems to be no actual diminution in auditory 
acuity. 
The explanation of these auditory and visual 
phenomena ha~ not been definitely established. Goodman & 
Gilman feel that they are d~e either to direct inJury to 
the cells of the spiral ganglion and tbe ganglion cells of 
the retina (ai evidenced by degenerative changes seen in 
these cells); or to secondary vascular changes occurring 
in tP,e organ of Oorti and regina (as evidenced by the 
spastic constriction of retinal ~easels with ischemia that 
follows salicylate intoxication) ~· Sable postulates that 
() tinnitus is the manifestation of the early stimulation of 
the central nervous system by salicylates, and that the other 
phenomena are the result of the confusion and depression · 
of the central nervous system that follows the early stimu-
lation. g. 
Resairatorl SYffiEtoms 
Taran & Jacobs reported on 2 oases of rheumatic 
carditis treated with intravenous sali.oylates. They both 
developed a hyperpneic by;e of tachypnea on the third day of 
treatment and died in heart £ailure, oompletely.disoriented 
and uith symptoms of respiratory distress p~edominating~ 
Another child, being treated with oral doses, developed an 
alarming tachypnea which neces~itated the cessation of 
0 
0 
Wegria &. Smull foWld that hYI>erpnea was the common-
est serious reaction to develop when blood salicylate levels 
of over 500 gamma/co. were established •. During these periods 
of hyperpnea, the serum carbon dioxide content ~ell as low 
as"25-.8 vols %. 98. The respiratory volume during hyper-
-
ventilation has beGn reported as high as 37 liters per minute 
ono day after drug withdrawal, with a fall to the normal 5 
liters/ minute 48 hours iater. 67• Quincke feels that there 
-
is frequently a subJective feeling of shortness of breath 
-
associated with this hyperventilation, and that the symptom 
would be bettei' described as dyspnea, rather than hyperpnea. 
67. Ryder et al reported on a patient with acute rheu-. 
-
matic cardttis(treated with therapeutic oral doses) who died 
after developing hyperpnea, blood signs of a respiratory 
alkalosis. and a toxic e.rs~Jephalopathy • .2.2!.• 
The mechanism whereby the salicylates produce these 
respiratory symptoms is contraversial, The condition appears 
similar to a diabetic acidosis. with a decreased serum 
carbon dioxide content, an increased serum chloride and a 
decreased chloride excretion. Ooombs nas £ound that the 
clinical and chemical symptoms can be relieved by adminis-
'tration of sodium bicarbonate which would indicate the 
<:.... 
possibility of a metabolic acidosis rather than a primary 
respiratory disorder. ~· However, most authors agree that 
··the prircary effect is stimulction of the respiratory center 
and development of a primary respiratory alkalosis uith a 
.' 
resulting depression of the arterial carUon dioxide content. 
The changes occur~ing in the blood are therefore thought to 
be the result. rathe~ than the cause of the hyperpnea. 
·67 t 32. ()6i, 
-- .- ~
Renal. ·Synmtoms,. 
Han~lick ~ound that administration of salicylate in 
the large doses necessary for .rheumatic fever therapy caused 
an albuminuria which was grea~est when signn of salicylate 
intoxication we:re present. This was true for both febri-le 
and afebrile patients. He also found pyuria and cylindruria. 
36. Other signs of decrease in renal functional efficieno~ 
-
have been reported. There is an increased B•U•N• and N.P.N; 
0 a d-iminished PSP excretion; and a small but constant decrease 
in urea clearance. Small doses of salicylate cause a 
diuresis. However, large doses cause reversible damage in 
the form of a partial suppression of water excretion by the 
kidney. The resulting water retention may give ~se to the 
so-called salioyl edema which never reaches the pitting 
/ 
stage, ~ut may manifest itself~as a sudden increase in weight. 
67, 25. However, usually saLicylate intoxication is accom• 
--
panied by profuse sweating and this may modify greatl,Y the 
. 
·degre~ of water retention. ~~ !&• A diminished urine 
volwme uith a subsequent hemcdilution may be especially 
important in cases of impending or.present myocardial failure. 
23. 
-
On the other hand, same authors are quite definite 
about the fact tltat salicylate therapy does not oause 
renal damage. Oobu.rn reports that none of his patients 
showed eviden~e o~ renal irritation. 15. Butt et al ~ound 
-
no albuminur~a in any of their patients. They did find 
white cells in the urines of 6 of the 51 treated patients, 
but they also found them in the urines of a o~ the 54 oon-
trols who were not treated with salioylates. a. Kieth & 
-
Ross also found no evidence of kidney damage in any of their 
70 oases. 42. 
-
Liver Damage 
The presence of urobilin, urobilinogen and sugar in· 
the urine of patients treated with large doses of' salicy ... · 
C lates bas led to consideration of' the possibility of 
damage to the liver by these drugs. Ketonuria has also 
"-been reported,~nd may bathe result of starvation follow-
ing anorexia and'~omi~ing; or may bo dne to some toxic 
"' effect on oarbohydrate,metabolism in the liver. 67. Butt 
-
et al, made careful studies of the li~er function of over 
100 patients and thoy could find no evidence o£ parenchyma-
tous liver da:rnage. IIowever, they did find that after 24 to 
36 hours of salicylate therapy, · tho~e was a. fall in the 
prothrombin level of the b~ood, but once the reduction had 
taken place, increasing the dosage of saliaylates di~ not 
reduce the level still ~rther •• The reduqtion was not 
great enough to in~uce any abnormal hemorrhagic tendencies·!• 
This brings up the problem of the relationship of 
0 
0 
salicyla~;e therapy to rheumatic purpuras. It is known that· 
hemorrhagic manifestations of rheumatic fever are not un• 
oon1mon.- There seems to be a seasonal .incidence with ·in .... 
creased tendency to hemorrhage in hot weather, It has been 
suggested that this may be due to the greoter demand for . 
Vitamin K which animals adapted to tropical heat are 1-rone 
to develop. At any rate, i:f.' the liver :ru.nction.is intact, 
the hypoprothrombinemia uhich is responsible for the 
hemorrhage may.be prevented or cu.red with oral doses of' 
Vitamin K. 67. Link in 1937 showed that salicylic acid 
-
was a degradation product of the.anti•coagulant dioottma~in• 
He was able to produce hypoprothrombinemia with salicylic 
acid in animals fed on low Vitamin K diet. 49. Meyer & 
-
Hmvard reported on 13 subjects in vhom 3 to 11 days of 
salicylate therapy oauseQ a reduction in prothrombin level 
to 50% of nor.mal~ There was a return to normal 2 to 4 days 
after cessation of the drug. They found that adndnistration 
of menadion~(synthetic Vitamin K) prevented the hypopro-
thrombinemia in these patients. 56. Shapiro found that 
q -
1 mgm. of synthetic Vitamin.K counteracted the hypopro-
thrombinemic effect of l gram of aspirin. 71• The action 
-
of the salicylates is similar to the action of dicoumarin. 
but is less intense • 67. 
. -
The hemorrhagic manifestations 
~hich appeared in the rheumatio.patients at the u.s. Naval 
Hospital in Corona, California seemed to be totally unre-
lated to salicylate therapy. Rheumatic purpuras were aloo· 
0 
seen in mant oases ot rheumatic fever with normal prothrombin 
levels and in cases who were not being t~e&ted with salioy• 
-lates. 8. 
.-
Taran & Jacobs noted that there were no hemor~ 
. . 
rhagic tendencies in any· of their treated cases. 87~ Coburn 
. -
found.projh~ombin le~els normal in the 6 patients on whom 
he did these determinations. 13. Probably the reason that 
. -
all patien~a receiving sali~ylates do not have hypop~o­
thrombinemia is that some haveeh~gher intake of Vitamin K 
than others. a. 
-· 
Qnick reports that prothrombin must be 
reduced to l/5 of normal before hemorrhage occurs .. 60. It 
®~~ . -
saems~that therapeutic doses would r~su.lt in such a severe 
reduction. However; when salic1la~es are being administered 
() to patients in whom surgery is oontemplat~d, large doses of 
Vitamin K should be given pre-and post-operatively* a~ 
-McEachern reported a cas~ treated with intravenous salioy-
lates who developed hemorrhagic phenom~na in spite of the 
administration of large doses of Vitamin o. The b~eeding 
eeased when salioylayes ware discontinued. 54. Unfor~unately. 
-
prothrombin levels were not done in this case, and we can 
only wonder whether intravenous thereapy, with its rapid 
. . 
induction of high salicylate levels;can aause more ma~ked. 
" . 
reduction in propthrombin levels than are seen with oral 
treatment• It would also be important to ~now if the liver 
function of this patient was normal wince the existence of 
cirrhosis may augment the hypoprothrombinemic effect of 
67. 
-
0 
Aller~i~ Manifestations 
Among the various manifestations of hypersensitivity 
which have bo&n reporte~ are: Constriction and edema of the 
pharynx;_ Dysphagia; Angioneurotic edema of the face; Pur-
pura; and urticaria. Edema of the glottis has also been 
rerorted, and may be the cause for the aphonia which is 
oacasionally seen in salicylate intoxication. However. this 
aphonia may also be due to 1) Central effects 2) laryn-
gitis secondary to hyperpnea or 3) an inflammatory laryn-
gitis entirely unrelated to the salicylate therapy. 
Asthma is another cammon manifestation of hyper-
sensitivity to salicylates. It is seen especially in patients 
~, with a personal or family history of allergic disorders. 
There seems to be a.high incidence of nasal P2lypi 
in patients who are hypersensitive to aspirin. Therefore, 
it is necessary to be cautious when administering this drug 
to such patients. Aspirin is considered to be among the 
most common allergy producing chemicals. However. Sable 
cites the work of Gardner & Blanton who disagree with this 
contention that aspirin is frequently an atopen. They found 
that in 90,000 allergic !iatients, only ~2% were sensl tive to 
aspirin. It was also noted that in over 100 consecutive 
ratients to whom the drug was adndnistered, there was no 
report of hypersensitivity. !t• 
Acute Salicyli-sm .. - McEachern reported on 6 cases 
~ 
treated with intravenous salioylates·who developedvvar,ying 
- -""" 
0 degrees of acute psychoses, including incbherent speech 
and disorientation of time and. place. This was accompanied 
by accelerated pulse rates and acute air hunger. He also 
had one ~atient who died after four intravenous infusions of 
salioylates. Post ~ortem showed pulmonary congestion and 
bronohO}~neumonia .. e,. Work VIi th experimental animals has 
~~"j 
indicated that the administration of glucose may lessen 
the intensity of degeneration and prolong life in such a 
patient who has been severly poisoned with salioylates 
during the course of thera:p~ 5~~-
It is important to realize that the manifestations 
Of salicylate toxioi ty may apr ear rJhen the !.:6 tient becomes 
-() ambulatory~ These signs will be relieved quickly wnen he 
io retu~ned to rest. 56. 
·-
0 
() 
• 
Aminopyrine 
Swift has reported that he h€\.S obtained very satis-
factory resu.lts with the use of aminopyrine instead of . 
the sqlieylates. He finds the drug.especially valuable 
when digitalis is being used, since the eombination of 
digit~lis and salicylates appears to be too toxic. 84~ 
-
He feels that the gastric irritability brought on by heart 
failure tolerates aminopyrine better than it does the sali-
cylat·es. Dosages of .3 - .5 gms 4 to 6 times per day are 
recommended. 85. However. this drug has the capaeity 
-
to induce agranulocytosis, Therefore, if amino»yrine is 
be·ing used, it is necessary to take frequent white counts 
and stop the drug immediately if the white blood Gamls drop 
.. 
to 4000-5000/ o .mm. ,!! • ~· This drug is generally 
considered too dangerous for widespread clinical use. 
------
' 
0 ADDENDUM::! 
SUCOINATES 
Very recentlyf- Gubner & Szucs reported on the use 
of Succinat~s in the treatment of Rheumatic fever. This 
form of therapy is based on the theory that rheumatic in-
:fection is concerned with enzymatic inhibit"ion. The authors 
present evidence indicating that there is widespread inter-
ference with enzyme systems which a~e involved with tissue 
oxidations, This includes 1) the porphyrinuria which is 
seen during the period following onset of rheumatic symptoms 
_and increases in intensity as the rheumatic process increases . 
in severity; 2) the lowering both of the Vitamin A and 
() Vitamin 0 levels in rheumatic fever which parallel the clini-
cal severity of the disease; 3} the deleterious effects o~ 
the sulfonamides in rheumatia fever, said to be due to in-
activation of certain respiratory enzyme systems; and 4) the 
increase in the oxidized fraction of glntath~one in fatal 
oases of rheumatic fever. Vitamins A and 0 and glutathione 
$ne ~ednoing substahces ~n&cn-~re inactivated by oxidation. 
Succinic acid is a.ls o an active redtlcing agent which is ver.y 
rapidly oxidized. It is thought that there is in rheumatic 
fever an "oxidative inactivation of tissue enzyme systems," 
Therefore, it is suggested that the "administration of 
suocinates not only helps to prevent inhibition of sQccinic 
dehydrogenase, theraby maintaining cytochrome in its reduced 
Q form, but n:ay also prevent oxidation and inactivat'ion of 
0 
0 
other respiratory enzyme constituents. n 
The preparation used was the calcium double salt of 
benzoic acid and succinic acid benzyl ester - (4~5.3 gms/day) 
Ascorbic acid was adroin&stered ~ith it (200 mg/day} because 
of the low Vitamin C levels seen in rheumatic ~ever. The 
~esults of 55 cases treated in this way were very encouraging, 
especially when compared with a group of 33 aases treated 
with 4-6.7 gms of sodiUm salicylate and sodium bicarbonate; 
' 
and another g~up of 32 oases treated with sodium salicylate 
and ascorbic acid. 
Comparison of Therapeutic effects of salicylate 
and Sltooina te. 
Total 
Salicylate 
65 cases 
reriod in hospital {days) 
Period on drug therapy(days) 
52 
48 
Indidence of drug toxicity (%) 19 
D11ration of' Fever(days) 
' 
Duration of Leukocytosis{days) 22 
Duration of AcCelerated Sed 
Rate( days) 
Incidence of carditis(%) 
Incidence o£ relapse(%} 
43 
69 
7 
Succinate & 
Ascorbic s~cid 
55 oases. 
34 
27 
2 
14 
24 
19 
0 
The inc~denoe of toxic reac~ions was much less in 
the group of patients trea~ed with sodium salicylate and 
ascorbic aoid than in patiento treated with sodium s~lioy-
~ 
late and sodium bicarbonate. 105 
-
The results obtained are enaourag&ng and indicate 
·that further- work should be done with succinic acid compounds. 
However, it s'tould be noted that the doses of salicylates 
that were used in this series were not adequate - and no 
a~tention was given to blood salicylate levels. The most 
promising :ee.a.tu.re of this new form of therapy is its appar• 
ently low toxicity. 
. , 
0 
D. DIGITALIS 
There is a difference of opinion as to whether or not 
digitalis should be given to children with congestive fai~ure 
in the presence of an active rheumatic carditis. The ev.a2u-
ation of the effects of the drug are diffi~ult since the 
favorable or unfavorable course of the carditis and congestive 
failure ma1 bo due merely to the normal progression or re-
gression of the disease. Heart block• auricular fibrillation, 
ventricular premature contractions, and nodal tachycardia 
have been observed in patients with a~tive carditis who weDe 
receiving digitalis - and in some instances these disturbances 
in rhythm disappeared when the drug wa~ discontinued. However. 
~ the same irregularities have been noted in children with 
active carditis who did not receive digitalis- It is be-
-
lieved that the myocardium may be especially snsceptible to 
the toxio effects of digitalis during an active rheumatic 
oardi tis. 102. 
-
Driffith et a~ find that the value of digitalis in 
adults is doubtful in the active stage of the disease, They 
feel tbat it is indicated only with onset of congestive 
failure during ·the course of active carditis, This has been 
rar~ly used since congestive ~ailure is a rare occurrence. 
trfben needed,~it is given ~rally in ~ll doses of l USP ~nit/per 
10 lb. body weight. l unit (gr.l l/2) is added for each 
additional day needed. to complete digitalization. A main-
"\ 
tenanoe dose of' l unit per day is used. 3'4• Remember, 
-" 
c 
· however, that the dosage .in ehildren is variable and depends 
mpre· upon the degree gf congestive failure than upon boey 
weight. 102 
-
Premature oontraetions occurring in the ao~te phase 
of the disease have not bean eliminated by quinidine. Rest 
and no smoking are of value for this. QUinidine and Pare-
drine hydrobromida have not been use~ul for correcting 
arrhythmias. 34 .. 
-
E.- DIURETICS 
Dependent or generaliaed edema is not a frequent oo-
• 
currenoe in the rheumatic carditis of children- 102. 
-
" However, when it does occur. the diuretics are considered 
the most useful drugs available. 
A rheumatic pneumonitis probably decreases the 
' . 
efficacy af the pulmonary vascular tree resulting in an 
increased blood pressUl'e in the pulmonary cirou.i t a.nd a 
Erimarl right sided failure. 
Theob~ollline sodium acetate l-2 gra ms daily or . 
anlinophy11in ( 200 mgs) q .-1 .d. usu.a lly a·re e:t'feoti ve • Row .... 
ever. if the edema and enlarged li~er persist ~ith absolute 
bed rest, digitalis and xanthine diuretics, it may be nedes-
[Jtti..: 
sary to us~ meroupurin or salyrgan intravenouslY lt{l/2-l co.) 
"!· ' 
These may oause. anuria and therefore should not be used if 
these are signs of renal impairment or inflammation, ~­
Extreme oases xnay call for paracentesis, 102,4 
F. OXYGEN 
OxygPn trettment is valuable in oases of rheumatic 
pneumonitis and congestive failure. It is given as long as 
the patients need help- given ~ia nasal tube passing ·4 liters 
of oxygen rer minute through a hwnidifier and into the naso-
pharynx, 34. 
-
Griffith et al. 34, o ontrolled series of cases-
-
100 R was given through the myocardium weekly for 5 weeks 
to 71 );rbmJ;ttthrough cervical sympathetic ga~glia and myo-
cardium in 63 pts; and no x-rays treatment to 67, who were 
merely subjected -t.o the procedure. It was found that marked 
improvement occurred in 10.4~ of control patients, whereas 
there was only 1.4% improvement in those exposed to the 
x-ray treatment. 
JiO .R!!1SULTS SL. IMfBOVEWNT MA RI\!SD IMP. 
Treatment with 
X-Ray-muooard. 49.4% 47.2% 
Treatment with 
X-Ray~cerv. sym, 
& myocard. 65% 
No Treatment-psyoh<?genht 59.7~ 
Therefore, there is no therapeutic effect from 
~ X•ray except for slight _psychogenic effect in that the 
patient thought that something was being done for him. 
-
0 
H • SERUM TH!5RA.PY 
The use of streptococcal antiserum has been tried 
by sevaraJ. authors. A monovalent antiserum was prepared 
£rom a strain of streptococcus that had been isolated from 
the blood of a ;patient with rheu.matie fever. The treatment. 
consisted of passive immunization ~ith antiser~ followed 
by active· immuniza~ion with vaccine or soluble antigen. 
Small(whoae work is cited by ryilson 102) was the only one to 
-
obtain successfUl results with this for.m of ther&py. All 
·other authors hav· reported that the method is unsuccess~l. 
25, 38, 1om, G6 • 
...... --- -..-- --
~ I. FFEVER THERAPY 
Chorea has been mentioned as one of the manifestations 
of the active rheumatic process. This is best treated by 
artii'icial fever therapy• pr•oduced by intravenou,s inJections 
of tr~ple typhoid vaccine or by heat. In comparing their 
results in 150 patients treated with fever therapy with 
those treated by other means (suoh as sedatives), sutton & 
Dodge,!!•li' found that the severity and duration of the 
arracks of chorea were greatly reduced. 
MILD 
MODERATE 
smvERE 
DU.HATIO!~ OF ATTACK OF CHOREA 
TREAT~n&NT WITH SEDATIVES 
27•4 days 
44 days 
62.4 days 
TREAT. niTH FEV~lli 
5.72 days 
8.56 days 
15.8 days 
0 
0 
In a later work• the same authors concluded that 
fever therapy seems to have a beneficial effect on the course 
of carditis. ·~he~ feel that it is· not _contraindicated fo~ 
treatment of ohorea in the presenc~ of rheumatic heart 
disease. eo. I~ studying 99 ohil~en·treated with fever 
-
therapy both for their first attacks of chorea and for 
subsequent attacks, they found that the inciden~e of rheu-
matic heart disease was significantly lower than in a 
comparable group of patients who ware not given fever 
therapy. 
Observed one to. three yrs. 
-Chorea 
.Polyarthritis 
Jieart Disease 
Deaths from Heart Disease 
Observed four to six yrs. 
Chorea 
Polyarthritis 
Heart Disease 
D(laths from Heart Disease 
TREAWED % UNTREATED % 
41.0 
s.o 
29~4 
~.96 
37.5 
32 .. 0 
26,0 
13.0 
51 •. 0 
33.0 
35.-0 
10.8 
There'.f'ore, fever therapy may have a beneficial 
effect on the sevarity of ~ubsequent cardiac lesions as well 
as,baing a valuable therapeutic aid in the treatment of 
chorea. 
0 
0 
II ••• Inactive or Quiescent Stage 
In the treatment of the acute phase of rheumatic 
fever, we were chiefly concerned with a rapi~ suppression 
~ 
of the rheumatic inflammatory process to minimize cardiac~ 
damage. Once we have acoomp~ished this, and th~ active 
disease process has sUbsided. we are confronted with the 
~ 
· problem of preventing recurrences of the disease. The 
importance of this is that the danger of developing perma-
nent organic heart disease increases with every recurrence.89. 
-
The rate of recurrence has been studied by Wilson & 
Lubschz in an analysis of 549 rheumatic patients. They 
have found that the overall risk of a maJor recurrence 
varies inversely with the age of the patien~. 
OVF~LL RISK OF REOURBENOE 
AG-E 
4-13 
14-16• 
17-25 
R"EOURR'!JIICE RATE % 
The risk has been found to be two ~o three ti~es 
greater in any.year f~llowing an acute attack of rheumatic 
fever than is the risk following one or more years of 
~reedom from activity. The risk for the year .immediately 
following an attack is 38.7%, whereas after one year of 
:freedom from a recurrence, the risk drops to 11.2%. After 
two years without an aoute attack, the chance of developing 
0 
0 
a recurrence is about 7%. 
However, the age and the interval of tiree elapsing 
since the ·last attack were found to be the only factors 
influencing the risk of future recurrences. There was no 
correlation between the rate of recurrences and the severity 
of the disease or the environment of the_patients~ There 
did not seem to be any significant differenoe in ~atients 
with chorea or with arthritis; or those with or without 
carditis~ 104. 
~
The risk of recurrence as reported by other authors 
seems to vary with the region in which the study is. made. 
The £igures for overall recurrences summarized by Allan & 
Baylor, l, are: 
... 
Kaiser • 50% (Rochester, N.Y} 
Swift • 60% (N. Y. c. ) 
Schlessinger - 58% (England) 
Howard & Mulls - 67% ( Canada) 
The ocou~rence of heart disease after rheurr~tic 
f~ver is generally placed at 60%. Rheumatic heart disease 
occurs most frequently in those patients having recurrences. 
The incidence is said to be greater among those patients 
showing polyarthritis than aEong those in whom chorea is 
the only manifestation. To again cite Allan & Baylor's 
figures; 
0 
0 
!UO!D~!WE OF CARDIAC I:nrOLVEI'liENT 
Investigator 
Ooomba 
!Uhayer 
Mackie 
Roward & Mills 
strong 
In ~rthritis patients 
75% 
75% 
68-78% 
68% 
38% 
In chorea patients 
44% 
25-50% 
68-78% 
68% 
45% 
~be works of Coburn & Swift have established the 
relationship of beta-hemolytic streptoaoooa.l infe,otion to 
both primary and reourreent attacks of rheumatic ~ever. 
These attacks. are most frequently preceded by a rather mild 
infection. suoh as a mild pharyngitis. Deeper infections 
such as otitis media or sinusitis are more apt to be followed 
by a glomerulonephritis. 89. 
- ~ ' l 
Therefore, _our main probi~ after successfully treat-
ing the acute phase of rheumatic fever is to prevent the 
patient from contracting upper respiratory tract infections 
vith bcta*hemolytic streptococci, especially for the first 
few years following the primary acute attack. 
A • 0 LIMATOTI:IE!V\PY • 
There is good reason-to believe that a v~rm dry. 
climate is beneficial in the prevention of recurrent a.ttaoks· 
of ~heumatio fever. 
Coburn took 10 rheumatio ohildren to Puerto Rico 
where he knew that nheumatio fever never occurred.. The 
children roma!ned free from streptoaoooal infection for the 
:> 6 months they were away, and none developed recurrent attacks. 
0 During this time Coburn was unable to isolate hemolytic 
streptococci from the throats of any of the 1200 natives ne 
stndied. However. on returning to New Yor~, all the children 
contracted streptococcal infections and rheumatic recurrences. 
29. Hill & Holbrook report that they have had no recurrences 
~ 
of rheumatic fever in any of ~he patients they hav.e sent to 
Tucson, Arizona, in the past 14 years. 37t There ,is a lower 
..... 
incidence of rhewmat!o feve~ in Naval stat~ons in subtr~pioal 
zones than in .any other climate. 34. The Ar.my Air Forces 
~
adopted the policy of sending all oases of rheumatiu fever 
oont~aoted in northern camps to southern camps. They kept 
these patients in so~thern o~mate for a poriod of 6 months 
to prevent immediate recurrences. 39 • 
..... 
Thomas considers the sending of rheumatic patients to 
Florida or Arizona for the spring and winter months fairly 
effective as a pro:hylaatia measure~ However, in order to 
accomplish its full purpose, it must be repe~ted yearly for 
five years. M. 
...... 
Hill & Holbrook feel that it is advisable 
for cnildren with rhewwatia fever or rh~umatic heart disease 
to remain in a favorable climate indefinitely, except tor 
short summer vacationssat home, or until the age has ~een 
reached where recurrent attacks are less frequent.- 37 • 
...... 
When advising rheumatic fever patients about changing 
their residence. their age and their cardiac cond~tion should 
be borne in mind. The older the patient is, the less im-
~ ~~ portent it is for him to make the change, since the l~keliho~d 
of developing a reourrenoe with heart damage is diminished. 
Also a patient who has already had repeated at~acks of rheu-
matic fever without cardiac involvement is said to be less 
. 
apt to develop heart damage in any subsequent attac~. The 
case where a change of the patient's residence to a warm dry 
olimate seems most indicated is the younger individual with 
an initial infection. with or without cardiac damage. 82. 
-
The impracticability of this form o~ therapy is ob-
vious. It is an extremely expensive undertaking, and there-
fore presupposes a relatively wealthy family to pay for the 
care of the patient during the prolonged residence in a: 
suitable clims.te. The vast majority of rheumatic patients 
0 \·.rould be unable to assume such a finan.oial burden since, as~ 
we have already seen. rheuma~io ~ever is predominantly a 
disease of the lower economic classes. However, the nation-
wide backing of a drive to raise funds for the control of 
rheumatic fever (similar to the ~idaly-spread efforts ex-
pended in behalf of the «not-so•widely-apreadn disease, 
roliomyelitis}. would be a step toward establishing convales-
cent homes for these children. As yet rheumatic fever has 
not been adequately npublioizedn, and. it remains to be seen 
whether s ·,me leading citizen of the future will mak.e the 
people "rheumatic :fever co, soiousn, Probably an ambitious 
undertaking of this sort ~ill have to wait until we have 
0 
definitely established the etiology of the disease. 
0 
0 
The oltmate o£ the southwest is thought to be 
beneficial because: l) Barometric pressure is unusually 
stable., and there is a year-found lack of storms11 Bheumatic 
attacks have been found to occur 10·20 times more often in 
worst areas of storm zones than in the calm warmth ot the 
tropics. 2) There is low precipitation and humidity. 
3) Mean temperature is fairly high. ·4) There is a high 
percentage of yearly sunshine. However, the ir.-adia tion of 
. 
the skin seems tcr have little to do with prevent~on of 
recurrences. Soma patients have sunbaths whereaa others do 
not~ and the results are no different in the two groups. 37. 
-
On the oth.er hand, exposure to su.nshine must be gradual and ' 
carefully r~gulat~d. 
It should be borne in mind that the southwest is not 
free from sore throats and upper res~irato~y infeot~ons. The 
same o~ganisms are present even thoUgh the number ot cases is 
smal.ler • !! . 
The value of. climatotherapy in treating the acute 
phase of rheumatic fever has not been definitely established. 
Activity is thought to subside muoh faste~ in war.m dry 
climates and it is believed that hemolytic streptooocc~ may 
die ou.t in this clima~·e. However, this has never been proved. 
34, 37. 
--
DIET 
we nave already seen thau special dietary measures 
0 
. 
... 
in the treatment of the acuive phase o~ rheumatic rever have 
bee.n or little value. 
Coburn & Fauli, !!• showed that environmental in-
fluences may increase the susceptibility ~o respiraior1 
~ract infections, pre~ispose to complications. and promote 
the spread of hemolytic streptococcal in:rection. Coburn 
~ Moore, ~. s~udie~ a groap of chi~ttren no determine if 
raulty ~!at is tne factor or conditioning which seems to 
increase the susceptibility or the host to rheumat1o reve~. 
An analysis· o~ tne diet or 50 children rrom a private school 
whion had been free from rheumatic fever ror e period ot 
6 years showed an adequate numner of calories ana an excess 
' or most other dietary oanponents. on the other hand, the 
diets or 25 rheumatic children rrom the public achools (who 
had bean rree from rheumatic attacks tor 2 to 10 years) 
were xound to have an uncompensated deficiency in eggs and 
bu8t~r. Another ~5 rheumatic children, who nad snffered 
sever recru.d.esqenees during ttte preceding two years, were 
round to have diets which were dericienu, not only in eggs · 
ana. bntter, but also in calcium, protein. phosphorous·, iron 
ana. Vi11amin A· 
~he poor Qiets were in most instances due to eco-
nomic reasons. Roweve~, in many cases, the child!en showed 
an aversion to certain essential zood constituents. 21 or the 
last-mentiom ct 2ti rheumatic ohilctren had strong Ui slikes ror 
more than one important rooct, anch as green vegetables, eggs, 
0 
liver, rish and/or meat. ~his &version fooa also seems 
responsiole for the oaau~renoe o~ rheumatic ~ever ~ong those 
ohilaren reoeiKing the advantages or lire in tne higher 
~ 
eoonom1o stratum. 0~ 14 such patients studiea. th~re was a 
high incidence or feeaing problems in ohildhoo~. 10 or the 
children uin not eau eggs, In only one instance aid 
rheumat~c fever occur in a child ~o waa ingesting the normal 
well•roun4eu menu of a family in ~be higher income brackets. 
In oraer to determine whether rheumatic susceptibility 
might oe moairied by improving the uutrition of rheumatic 
children over a long perioa of time, the diets or patients 
wiuh quiescent nh~tic fever were supplemented with four 
() aggs each day ~ since eggs are most frequently omitted from 
the diet ~ither because of the cost or because ox the patients 
taste. The aeries was small - 42 cases were observed. H~r­
ever, the results were encouraging in that most or uhe children 
gained an average of 8 pounds ( ~ overweight children lost 
an average ot ~pounds), ~hose children who contracted beta-
he.mo~ytio streptococcal inreetion or tne uppe~ respiratory 
tract escaped clinically recognizable rneumatic rever -
although at times there was a slight elevation in the sedi-
mentation rate and a rise in the antistreptolysm titre. These 
results are not conclusive, especially since there were no 
adeqqate control studies car~ied out. However. they do 
indicate that the customary s~sceptibility to rheumatic 
fever is not apparent after 4 eggs are added to the diet. 21. 
~
0 
warn~r et al; 92,report that the addition of fresh milk and 
......... 
butter to the diets of rheumatic susaeptibles tBsults in the 
reduction iu the incidence of rheumatic fever to less than 
o:a.e. third, 
It does not seem possible to establish .. any one of 
the dietary facto~s as a sreoific determinant of suscepti-
bility to rheumatic fever. Several deficiencies seem to be 
more important in influencing susoe·ptibili ty than any one 
' 
defi~i~ncy: 
Oal·cium appea. · s to be an important factor. The 
absorption of calcium depends on adequate amounts of 
Vitamin D or exposure of the body to s~light. The rheumatic 
() child is not subject to either of these. Oalcium plays an 
important role in normal irritability of muscle and nerve 
tissue; in the clotting of blood; and perhaps in the permea-
bility of membranes ... all of which may be altered in rheuma.tic 
fever. Also, the striking prevalence of poor musculature and 
poor dental development in rheumatic child~en may reflect a 
mild prolonged calcium de£iciency~ 21, 32. 
--
Proteins are essential components of intraoellnlar 
enzyme systems and they play a fundamental role in tissue 
repa~r - especially in organs with hoavy work loads such 
as the heort. Since the proteins, such as eggs, meat, and 
dairy products are the costliest of foods, the economic 
statns of the majority of rh0umatic patients may make protein 
lack an important factor conditioning them to developm~nt ~r 
0 
recurrence of the disea~e. 2l• 
-
Iron does not seam to be as tmportant as these others. 
Iron r~quirements increase tremeildousl;v at puberty, and if 
an iron deficiency were a significant ~actor tn suscepti-
bility, there wou.lt1 be an intensification of the disease at 
ruberty. Howev~r~ the incidence of rheumatic fever actually 
falls sharply at this aGe• · ~* ~· 
Vitamin A blood levels have been fou.nd to be low in 
patients with quiescent rheumatic f~ver who were on a poor 
diet. rhe Vitamin A level decreased still £urther when the 
ohset of rheumatic fever occurred. 21. However, Kuttner 
-
feels that reinforcement of the diet \nth Vitamin A, B 
() Complex; C & D does not protect against development of a 
rheumatic attack. 43. 
0 
-
C • IMMUNIZATION THERAPY 
The concept thet rheumatic fever is an allergic 
phenomenon and rheumatic inflammation is due to hypersensi~ 
ti vi ty has led to attempts to desensitize rheums tic sub jeots 
by tntravencus ¥&ccination with hemolytic streptoooooi. 
~ilson's study in 1930 of 172 su.b~eots indicated that 
there was a diminished ~hewmatic activity due to the immuni• 
zation. 45% of the tr~ated patients remained free from re-
oarrenoes for 16 months to 2 year~ ~oll~Jing treatm~nt, where• 
as only 18% of the control group escaped recurrent attacks 
during the same period of time. 
o. 
0 
.n 
--
The patien$s were treated with heat killed cultures of 
~.J. 
hemolytic streptocoooi and given a total of 10,000,000 
microorganisms in a series of 9 to 12 injections. However, a 
group of patients who were given a sGcond series of inJections 
the following year exhibited mora recurrences than those who 
received only the first series~ Also, when extending the 
.. 
study ~ut over a period of three yea~s and comparing results 
with those obtained using verious other antigens. Wilson 
conolnded that there was no significant difference between 
the treated. sub3ects and the controls. 102. Coburn & Pauli, 
-
22, could find no evidence that immunization increased the 
- . 
resistance to streptocoo~us infections or rheumatic recurrences. 
Wasson, 94, in 1938, and Wasson & Brown, 95, in 1940 
- -" . 
and 1942,·!!, reported that the incidenoe of recurrences 
was more than four times greater in their control sub~acts 
tlmn in their immuni~ed sub~ects, although 10% of the immunized 
patients still developed reonrrenoes. 
At present, not enough work has been done on this 
subject and the results a~e considered encouraging but in-
conclusive. 66. 
-
D. TONSILLECTOMY 
The frequent oaourence of tonsillitis or sore threat 
in children preceding either the primary rheumatic infection 
or a rheumatic reorudesenoe suggested the tonsil as a 
probable portal of en try- of the "causative organismn and· foclls 
of infection., However, even complete tonsillectomy or 
adenoidectomy does not remove all the lymphoid tiss~e which 
may aot as a possible source of infection from the mouth. In 
·fact, the elinical experience of many workers in this ~ield 
' has led. tb.em to the belief that the to:nsil plays a ~ole in 
immunizing the body against pathogenic bacteria and that a 
ahild is more susceptible to inf"eotion following t.onsilJ.ec-
tomy. It is ·a generally accepted opinion that rewoval of 
the tonsils should be avoided under the age of 5 years. 102. 
-
Wilson reviewed the earlier literature and found that 
the ov0rall recurrence rate of rheumatic attacks in 1,232 
patients after tonsillectomy was 43.1~, whereas the ~tudy of 
594 control patients showed that 48.-5% of these patiep.ts 
developed manifestations of rheumatic activity. The data 
, 
on these patients were inconclusive. Therefore, Wilson made 
a stu~ of 413 patients ~ver a period of one to ten years~ It 
was found the average numb r of rheumatic attacks a child 
may anticipate decreases as the age increases~ regardless of 
whether tonsillectomy is r.erfor.med or not. The inoidenoe of 
recurrences was lower in the control group than in the 
tonsillectimized group at every age. However,. since these 
statistics were compiled from hospital records. it is probable 
that the children who escaped tonsillectomy had been less 
susceptible to recurrent infeations and therefore tonsilleQ-
tomy was deemed unnecessary. It is not a V'al id o ontX' ol group 
with which we can compare tho trP.ated patients. However., 
: 
\ 
0 
tonsillectomy did ~ot seem to have any effect on recurrences 
of rheumatic activity. 102. 
-
Allan & Eaylo~, l, have reported on 108 patients·who 
-
were- subjected to tonsilleetomy (49 of these patients, how-
eve~. were inolnded in ~ilson•s review of the literature). 
Their figures agree with those of Wilson • 43.5% of the 
patients developed recurrent attacks after operat~on. They 
found that recu~renoas were oo~on in the first 5 years after 
operation, and most of the patients who suffered repeated 
reorudescen~es in this period died of rheumatic heart 
disease. The incidence of heart disease developing fn 
tonsillectomized ~atients was found·to be 51% among the ar-
thritic patients and 2&.1% among _the chorea patients. This 
is somewhat low~r than most of the other figures reported. 
Most stgnlficant however, was the fact that of 49 patients 
\*tho di{t not have car!liac involvement at the time of tonsil~ 
leatomy. only26 ( of 12.2%) developed rheumatic heart 
disease subsequent to the operation. 
From the results which have been obtaL::.ed over a 
period of years~ it tnerefore seems evident that tonsil-
lectomy does not significantly effect the recurrence rate of 
rhettmatic fever, It is not adVisable to remove tonsils only 
as a proventive measure in rheumat.to children. Rowev~r, 
if recurrent attacks of tonsillitis are-present in a rheumatic 
child, the tonsils shou*d be ramovad during the quiescent 
0 
0 
stage o~ the disease- nev0r in the active stage. The 
operation shou.ld be :p~eoeded and folloned by sul:ronamide 
therapy. 66. 
-
If the patient~has sho11n no signa of carditis duriD6 
tr·~ 
the primary rheumatie infection, it· is possible the t 
tonsilleetaroy may be beneficial. Further work wo~ld be 
neoessa~y before such a procedure wo~ld be recommended~ 
. 
·o E • S.ALI01'T.JiTES PROPRYLACTIC.ALLY Schlessinger attempted to rrevent rheumatic recurrences 
with the use of 20 to 30 grains of salicylates daily for 4 
weeks, following the ons~t of pharyngitis or tonsillitis. He 
reported that this form of ~rophylactic therapy prevented 
serious relapses following tonsillitis - and that when acute 
rheumatic fever or carditis did OQcur, it took a much milder 
form, and virule~t fatal forms of pericarditis r·arely occurred. 
He believes that the salicy~ate •damps down the whole rheumatic 
process'.r and there is ·a prolonged latent period between throat 
infection and relapse. The acute rheumatic fever is replbced 
by a milder form of 1'miniature rheumatic fever". Re also 
advocates the administration of a course of aspirin routinely 
to rheumatic children aftor tonsillectomy. 69 
-
Coburn & Moore, 20 , in 1942, studied 186 young 
-
rheumatic patients before and after beta-hemolytic strep-
tococcus pharyngitis. 47 of thes~ patients with positive 
throat cultures ~or beta-hamolytio streptococcus received 
4 .to 6 gms. of sodium salicylate .daily £or 4 weeks. Of 
these, one dev~loped rheumatic fever and 46 esoaped, 
Fifteen of these showed a brieX asymptomatic rise in 
sedimentation rate a few days after p~ophylaxis was stopped, 
but none developed signs or symptoms of rheumatic activity. 
Of the 139 untreated oontrol patients, 82 escaped, but 
57 developed a rheumatic rec~udescence. By doing oareful 
immunological studies on their patients, they were able 
to show that no antibody'occurs in these patients, 
and therefore, maintaix .. ed th.a t the action of ealicylatee :wa~ 
in prevention of for.mation of antibody, 
" 
Derrick, at al, (alrea~ cited under Mode of action} 
25, found that aspirin prevented the development of arthritis 
in serum sickness - and that it inhibited the rise in a~ti~ 
horse-serum prec.i:pitins.- However, it did not really S\lppress 
antibody formation or prevent antibody-antigen reaction 
since it did not prevent bhe development of urtica~ia (which 
~ 
appeared more intense in the treated oases. 25 •. 
-
Leech, 45, and ~erry, 59, using daily doses of 1.3 
- -
to 2 grams of salicylate~ over a period·of months found no 
great difference between treated and control groups, as far 
~ as number of recurrences were conoerne~~ 
Most recent authDDs feel that the salicylates do not 
protect susceptible.per~ons from recurrences, but may task 
the sumptoms· of an acute rheumatio attaok when they are 
given dnring the period of a streptococcal sore throat 
and. for several weeks thereafter. Therefore, they do not 
seem to lend themselves to general prophylactic use. ~4.66,29. 
---
There seems to be a latent period of 1~4 weeks 
foll~ling the original streptoooooal inte~tion before rheu-
matic fever appears. 89. The Ar.my Air Forces rheumatic 
-
fever control program reports that salicyla .e should be used 
in patients with br->ta-hemolytia streptococcal ixJ.:t'ection in 
doses of 6 grams r,er day for 10-14 days-but not long enongh 
to mask the early symptoms of rheumatic fever- and that it 
0 
does aid in prevention of primary rheumatic ~ever in saoh 
:patients when used this way. They tee+. on the other band; 
that the ef~ect in prevention of recurrent attaoks of rhen-
ma~io fever by use of salioylates should be further e~lorea.a. 
< -
This method baa not been widely enough used to giv~ 
a. clear statistical evalnation of its merits. It is still 
experimental, as is the case with immunization therapy. 89. 
-
F. SULFONAMIDE PROPHYLAXIS 
The relat~on o£ respiratory tract streptoooc~al , 
infection to rheumatic £ever attacks has led to an att~pt 
to prevent attacks and recurrences-by preventing strepto-
coccal infection. The work was begun by Bnttle et al.9, 
-
in 1936. who ~eported that doses of sulfanilamide smaller 
than the therapeutic dose, when given to mice before strep-
tococci bad a chance to invade and multiply in the tissues, 
were effective in preventing beta-hemolytic str~tococcal 
infeetions. 
Thomas et al, 91, administered 1~1.2 grams of 
- . 
sulfanilamide- daily- for 4 years from October to June to a 
gronp of adole$oent and young adult rheumatic pa~ients and 
compared the resu.lts with a control group. They found. tjla. t 
the patients taking prophylactic snlfan1lamide did not de-
velop a single maJor attack of rhewnatia fever, n.ot did they 
suffer from any acute beta-hemolytic streptoooooal infection. 
:) On the other hand, 15 ma ~or episcdes "Of rheu.ma tic infection 
.• 
" 
0 
occurred in the control group (constituting 10% of the group), 
~d another 5 patients developed questionable rheumatic 
attacks. Positive throat cultures for beta-hemolytic 
st~ertooocous were 3 times less carnmon in treated subjects 
than among the controls. Coburn & Moore, 17, treated 184 
-
rheumatic patients with prophylactic sulfonaiDldes. ana on~y 
. . 
one of their ~atients developed a recrudescence. Kuttne·r;39._ 
-
studied 108 children over a period o:r 2 years. .Among the 
54 treated patients, one developed a pharyilgitis .. without 
rheumatic sequelae in 19401 and another developed mild 
rheumatic mani~estations in 1941 following a streptococcal 
sore throat. However, among the 54 control patients, 30 
. . in 1940 
contracted streptococcal pharyngitis, after a latent period, 
14 of these devoloped definite rheu.ma. tic re.Jttrrences. In 
1941, 18 of the patients o Qjj. tracted streptoCOil cal pharyn-
gitis, and 9 of.these developed definite rheumatio recur-
renoes. 
. 
Up to Odtober, 1944, prophylactic snl:f'onamides had 
be-en administered to rheumatill pa. tients for a total of 815 
patient seasons. Only a recnrre~ces were noted, \~ioh is 
an incidence of less than 1~. The recurrence rate in the 
control groups averaged from 10 to 35%. 
In the wi.~.!ter of 1944, the high inoidenoe of atrep• 
toooccal infectio~ in the arme.d :forces (50% of all·hospital · 
~ admissions} prompted the initiation of a program of' na ss 
\ 
\ 
0 
prophylaxis. 250 1 000 Naval trainees were given 1 gram 
(usually} of sulfadiazine from December to march, and another 
250,000 were observed as controls. During this period, 
. ' 
ho~italization for severe respiratory disease was reduced 
80 to 90% and streptococcal infections wore reduced 85% 
among the treated patients. The rheumatic fever rate dropped 
markedly, so that in a certain instance there were 14 oases 
in the control group for every one esse in the treated 
personal. The attack rate of rheunatic fever decr-eased 
gradually over a course of several weeks. ~he rate dropped 
from 87 ~er thousand in the first week of ther$py to 6 per 
thousand after 4 weeks or therapy* A comparison with the 
() manner in which the scarlet fever rate dropped is a goai 
illustration ot the difference between the two diseases-
rhernmatic fever supposedly being an allergic reaction pro-
, I 
Auced by sensitivity to the beta~hemolytic streptococci, and 
scarlet fever being directly produced by x beta-hemolytic 
streptococci. 
Attack Bate / 1000 
Rheumatia ~ever 
Scarlet Fever 
Week of rrophylaotio Sulfadiazine·Adm~ 
l 2 3 4 5 
87 45 45 19 6 
70 45 0 0 0 
Repeated prophylaxis on the same group after a lapse 
ot ~onsiderable time i$.just as e~fective as the first tiree. ~~ 
If the sulfonamide therary was begun after the strep-
tococcal infection had occurred, but prior to the ap~earance 
~ of acute rheumatic fever, the rheumatic attack developed 
~~ 
0 
regardless of the medication. 89 
-
Dosage and Administration 
Thomas & Franca, 90,1n 1939, used 1 to 1.3 grams of 
sulfanilamide daily and obtained good ~roteotion ~rom 
resp1ra~or1 infections and rheumatic attacks. Blood levels 
rangea. from l to 5.5 mg per lUO cc .. b1ood·. In 194.4 Thomas 
~, .reported that .5 grams per day is slightly less ef£ective 
than 1 gram per dey in adults. Theoretically it is preferabl& 
to give .5 grLllls every 12 hours, since the drug is largely 
·excreted in a few hours 1~ l gra~ is given in a single dose. 
,. 
In the Army Air Forces .rheumatic fever ooutroi . 
program, it was fou.M that 4 grams of sulfadiazix.~.e given in 
a 48 hour :period produc6d a definite; but b"rief reduction 
"• I • 
in hospital admissions for respiratory disease. 6 grams 
over a ~eriod of 3 days reduced hospital adndssions about 
?5% for 12 days. l gram daily effected a continuous re~ 
duction in hospital admissions for .respiratory disea~e. 
This is more effective than is the intermittent method if 
not properly timed. Comparable results were obtained using 
~·5 grams per day. ~· 
Fullerton, 29, ~eels that a dose of .5 grams. twice a 
-
day is adequate. ~here streptococcal in~eotions are preva-
1 en t • tre8 tment should b : instituted .for at least 3 y~a.rs 
after an attack of acute rheumatic fever. 29. 
-
It is important to start sulfonamide prophylaxis 
... 
before the patients returns home from the hospital or 
,, 
convalescent home. 3ven if the aediment~tion rete has not 
fallen to normal, the· sulfonamides should be administered 
as soon as the patient is free'of arthritis, ~ever and 
other syl'J}.:ptoms in the absence of salicyla tea. !n order to 
try and avoid toxic reactions, it is suggested that the 
patient be started on .5 grams per day for 3 weeks while 
protecting him from·o1ose contact with crowds. Then 
increase the dosage to l gram and continue the adrntnistration 
of l gram per day eve11y day for at least five rear~• These 
patients no longer suffer from b~cterial infections. This 
method ht:ts been proposed by Thomas, who has had excellent 
results with its tl:le. One of the patients has boen taking 
prophylactic sulfonamides for a years continuously~ 89j 
-The year-round adttdnistration avoids the occasional acute 
attack that occurs during the summer. sa, and prevents many 
-
toxic mani~estations which are most likely to ncour shortly 
after ·the dru.g is started. 44. 
-
Coburn's observations in 1944 indicate tbat oontinu• 
ous ingestion o£ 1 gram o~ sulfadiazine is adequate to:· 
l) check a well-advanced streptococcus epidemic; 2) check a 
strap. outbreak at its onset; and 3} protect 65~ of suscep-
tible patients from implantation \Uth bacterial respiratory. 
,, pathogfms. .A cop.tintlo\ls daily dose of .. 5 gms. of sl,llfa-
diarz~i .• e t"Jill eive a mean level of 1.4 mg/100 co~ in blood. 
and perhaps .a mg/100 co. in the respi~atory tract secretions, 
~ This is almost 85~ effective in pre~onting tmplantation with 
0 
b,<>ta-h •molytio streptococci. 'The incidence of rhew:na tic 
fever among the men receiving chemoprophylaxis was 15% of the 
incidence in the co,ntrol groups. 14. 
-
Coburn and Moore discontinued the administration of 
sulfani~amide in over 100 rheumatic patients who-had been 
receiving chemoprophylaxis. Hemolytic streptococcal sore 
thraots developed in 32 oases • and 40% of these had an 
' attack of rheumatic fever. This demonstrates that the pro-
phylactic effect does not extend beyond the period 'during 
which the sulfonamide is being administered. 19# 
-
Reeently, the firs·t nnfavorable report on the effect 
of chemoprophylaxis on rheumatic fever appeared from the 
rr Army Air Forces. Warren carried out a prophylac!tc pro• 
-/ 
gram fro January to May 1945 duri,ng which time he adminis-
~ 
tered 1 gram of sulfadiazine daily. · Thdugh the incidence 
of beta-hemolytic st;r:eptoooooal disease was reduced in the 
treated group, the reduo~ion ·was not even 50~. Also, among 
the- treated group of patients who developed streptocoooal 
infection, the incidence of rhe1.1matio :rever wa.s t-wice ae · 
great as the incidence among the control group of patients 
•.r;ho a·ontraoted str~ptoooooal infections. The poor results 
may be part~y aeaounted for by the appearanQe in this 
series of· sulfonamide resistant strains of hamolytio strep-
tococci. 93. 
-
·o 
0 
Sulfonamide Resistant streptococci. 
The appearance of sulfadiazine resistant strains o! 
beta·hemolytic streptoo~cci has been more or less antici• 
pated ever since mass chemoprophylaxis was undertaken. When 
the Ar.my Air Forces began the widespread usa of sulfadiazine. 
both prophylactically and therapeutically, special labora-
. ( .,. 
tories were set up to watch tor the appeata~~e of sulfona-
• 
mide resistant strains of streptococci. rt ls of interest 
to note that the first resistant strain was found a~ an 
induction center, in spite of the fact that sulfonamides 
were used much more extensively in all other fields an4 
il~:.t~ 
stations. This strain was markedly resistant to sulf~~ 
t,{ 
~ dia~ine, but responded well to penicillin. 57, Ra9ent~y, 
-
the report was published of the first extensive epidemic 
to arise caused by several strains ot sulfadiazine • ~e­
sistant beta-hemolytic streptococci. This ocour~ed in 
va.riou.s camps o:f the u .. s. Navy. The strains were especially 
prone to oause scarlet fever, and this was the predominant 
complioation •. However, the incidence of rheumatic fever 
rose from a low of 3 per thousand to a level of 15 pe~ 
thousand after 3 months. This outbreak occurred during the 
course of a controlled sulfadiazine prophylactic program. 
It was found that increasing the dosage to 1-5 or 2 gms per 
dey did not prevent streptococcal disease. It was also 
" 
noted that the incidence of streptococcal infection was 
~ greater among the treated- personal than among the control 
group. This has led to the conjecture that 1) either the 
resistant st~ains had so altered their enzyme systems thut 
the small concentrations of sulfadiazine in the host acted 
as an a~ded growth factor or catalyst; or that 2) sulfa-
diazine inhibits the growth of certain organisms in the 
throat which nor.mally compete for food requirements with the 
streptococci. or produce substances which have an anti-
biotic effect on the beta-hemolytic streptoeocc~s. 107. 
. -
Demer•B found that the development of resistance to 
antibiotics is the result of a mutation in the organism and 
that the strain produced in this manner maintains its 
res'istance indefinitely. Such mutations can also occur in 
() the absence Of ,exposure to an antibiotic agent. His worlt, 
and reaent observations, suggest that resistant strains 
may develop as a·resttlt of widespread use of any given 
chemotherapeutic or antibiotic agent. In addition to ·re-
oistant strains of atreptoaocci, sulfonamide-resistant 
strains of gonococci and penicillin-resistant struins of 
staphylocqi have_been reported.~· 
Shott studied 15 strains of hemolytic streptococci 
which were highly resistant to sulfadiazine, and found that 
they were more sQsceptible to sulfathiazole or sulfa~ ~ 
ll {~5 ~· 
pyrazine. Therefore it seems that resistance to one iulf&aa• 
~ r ~ ' 
mide may·not necessarily indicate that the organism is re~ 
sistant to all, or any, of the others. 'l3, 
-
~he occur~ence o£ sulfonamide resistance strain~ 
shou4d encourage the limitation of both therapeutic and 
'" 
prophylactic administration of sulfona~ides to cases in 
which adequate justification exists. ~· This would 
indicate that any furthe~ mass chemoprophylactic programs 
to out down the incidence of respiratory infections among 
-
the normal healthy general public is to be avoided. However, 
the prophylactic use of sUlfonamides in rheumatic patients 
should be considered a most important part of the thera-
peutic measures available today. It has been.the most 
·· encouraging advance in recent years - and the one which 
gives the most promise as far as decreasing the incidence 
4t of heart disease. 
l 
Toxicity 
Slocumb & Pol ley, 74, report that the administration 
-
of l-3 gm.s/day of sUlfanilamide led to toxic reactions in 
10-40% of the cases. The reuotions include rash, nau.sea, 
and mild fever. It may be possible to start the sulfa 
again after intermitting it fo~ a few weeks• Discontinue 
it if the symptoms recur~ Lowering o~ the white count is 
the.most significant change and daily counts shonld be done 
....3 
on patients with less than 4000/mm and 45~ or less polys, 
When in aoubt, discontinue the drug~ Usually agranulo-
cytosis; when !t develops, does so late in the first month. 
Therefore, whi'te blood oou.nt should b·e checked twice a week 
0 
n 
for the first month while the patient is taking sulfa. 
Anemia very seldom ooours. · However. advise hemoglobin 
d.ete:t>mination. 
Hansen et al, ~, reported on one case where lewco~ 
penia of 1700/ mm 3 with 12% polys occur~ed after sUlfa-
thiazole was substitntad for sulfadiazine in the fifth month 
of m)dioation. 
stowell & Button, ?7. 
-
reported on 46 patient saasons 
with daily doses of 1.5 to 2 gms sul~anilamide in which 
there were 2 flare-upsj l death from agramulocytosis in a 
patients who had been taking ,6 gms sulfanilamide tvriae a. 
:.ay fo.t' 26 days; and 25% ware :for.oed to discontinue treatment 
beeau.se of toxic reactions. 
The consensus of opinion was that the risk of toxicity 
'Was small enough to warrant the use of sulfanilamide for 
:prophylaxis against rheumatic fever • .!!:.. Whatever doubt 
there was seems tq have been diepelled by the la~ge-scale 
Jstudies on toxioi ty ea~ried <>ut by Holbrook in the Army and 
Coburn in the ~avy. 
Holbrook, 3~. found that 4 gms of sulfadiazine given 
:Ln 2.4 hou.rs caused no serious complications in 18.000 troops. 
25.000 troops were given 2 gms in one dose ~ only 13 reactions 
(skin and ? fever} occurred~ The ·very severe reactions were 
~:!! 1Hl~§0 Wll@. nao;~j}~@V!O\l§ lli:ijv@l'f .of su.ltonamia.e reacti.Ont:~ 
' ·~ 
that had not been reportea. Major aisabilities were skin 
:l J.esions occurring be'tiween rirst and 16th way o:t: drUB 
0 
0 
ad.rninistret'ion. One :patient a.eveloped hemolytic anemia which 
was successfully treated with transfusions. ~here we~e no 
-
renal complications; no neu~ropbilic leukopenia ana no deaths 
-
in ~he 40.ooo. troops. Ir the reacuors to sulfonamides are 
eliminated, a.osea ut .5 to l gm sul~aaitiZine daily oan oe 
given with almost complete lack u~ risk. 
Ooburn, 14 1 reporus un~t the only unboward effect o~ 
-
mass ~ulfadiazine p~ophylaxis 1n the u.s. Uavy is tne oc~ 
curl'."'enoe of evaneecenu J."ashea in .5,~ ot the cases: t:~.nd. 
a.angerous constitutional d1stu.rbances occur in only •. Ol%•-
these consisted or exfol1au1ve dermatitis and granulo.oyto• 
penta .. 
Sulfadiazine seems to be the drug of choice. sinoe2 
the 1nc1denee of toxic reaetiona is less with iu thhn with 
sUlfanilamide. It is also poss1ble to maintain adequate 
blood levels with a single aaily dose. so. 
-
Sulfanilamide gives Just as good protections as 
sulf~d1az1n~ and it ia not toxic in low uosaga. However, 
' 
·~~ t 
sulfadiazine is the drug of choice. Sulfamerazine may prove 
to b¢ superior to these due to its slower rate of excretion. 
B~t, as yet; no large-scale studies have been oarriea out 
on tb.ise drug. 
Wo safeguard patients receiving prophylactic sulfa:-
keep them in beat physical·oondition with a good diet- Avoid 
unusual factors which might influence healah.suoh as im-
0 mu.ni21a tions. Do i'requ.ent white blood count. Have patient 
0 ~aport any rashes or sore throats immediately. sta~t dose 
at ,5 ~· and increase it to l gram after 3 weeks. 89. 
-The recent developments in oral penieillin therapy 
make tha~ drug now feasible for prophylactic use.. However, 
penicilli~ also has no effect on the occurrence or re-
crudescence of rheumatic fever when used in treatment of 
acute hemolyt~o streptococcal infections of the thr®at~ 34. 
-
Oom~li~atias Faoto~s:-
The prophylactic administration of sulfonamides is a 
valuable, but a$ yet incompletely-explored field~ There-are 
several difficulties which might arise from this for.m of 
thera!)y, and they should be lt;ept in mind and investigated 
further. 
l) The toxic properties of the drug (already discussed) 
· 2) The develQpment of sulf'onamide-resista·qt strai11s of 
bc-ta ... b.emolytio streptoo9ooi ( alx-ea.<ly .discussed.) 
3) The s.dministration of a potentially toxic drug to young 
ohildren for 5 years or more may cause interference 
with normal growth and development • and exert an 
adverse effect on the bone marrow* 44. 
-
4) Sulfadiazine given over a veriod of years may leave the 
patient unduly susceptible to infection tmen the drug 
is withdrawn4 ~here is, as yet, no data on this. 44. 
-
5) Sensitization to the drngs may occur so that the patient 
my be u.nable to tolerate therapeutic doses. 44_. How-
-. 
ever, both Coburn; !!• and Holbrook, ~; reported that 
0 
0 
there were no untoward reactions when treating such patients 
with therapeutic doses for acute infections. 
G • PSYCBOTHERAPY 
n~hose intereste.d in psychosomatic medieine are 
thinking in ter.ms of the necessity for the 
organism to maintain a hamoostatia equilibrium 
within itself and within its environmental 
field." Dunbar. 
The rhewnatiq patient is described by Dunbar· as an ~ ..,o f("'A' 
vvfi;J-M- tr,' -. -v'' 
i!liDlature indivi<!ual who has never been able to decide '.AU vWt tviwttifJ 
~ ~- . 
whether he is male or female 1 or which he would like to be. ~~...,. 
His •r:preoocu.pation with his sexual role impedes any 
endeavor to effect a relationship ~ith the environ-
ment on more mature te~s. Therefore. he escapes 
the authority conflict and in his attmmpt to addust 
to·hie environment he concentrates on his sexual 
role and on his social relationships. Re attempts 
to please; irrespective o~whether the person to be 
pleased is sup~rior. equal, male or female~ The 
conflict to which he is subject makes his need to 
please especially acute. u 
' 
~he persone.alit~ types were found to differ in those 
patients with acute rheumatic fever characterized by 
polyarthritis• or with a history of several attacks but 
little or no cardiac damaee - and those patients who enter 
with heart disease without a clear history of acute rheu~ 
matia fever. Recurrences of rheumatic fever could be 
prevented by brief psy~hoth~rapy in a large ma~ority of 
the polyarthritio patients wao had little or no cardiac 
involvement .. 
0 
In patients with existing cardiac damaee, mistaken 
diagnoses of renewed rheumatic activity and cardiac 
decompensation are often made on the basis of palpitat.ion 
due to an anxiety neurosis. It should be bo~ne in mind 
that··anxiety and guilt, as well as l_~~~ty(a:re oharaoter-
r'( ,-t/1 I>"-' r: istias ·of rheumatic patients. liYJ vt-~c.r~ ~£~ ~t-a vt'\4..Ct ~ \ "' 
Psychotherapy, according to DunbarJ is of little 
value in rheumatic heart disease with severe valv&lar 
damage. However. such a patient may be rescued from a state 
of n~hronio invalidismn if ppysioians will avoid. "playing 
into the hands of the patient's masochistic tendencies ••• " 
r~he artificial ideal of being a good person in the family 
0 and having to .swallow rar:e should be modified•" 
Brief psychotherapy gives more encouraging results 
in rheureatio fever patients with little or no cardiac 
damate~ The atients should be given a sense o£ security~ 
Pen sonal relationship with the doctor should serve as an 
aati ve outlet fo.t• them ... and gradually ·this o11tlet shno.ld 
be shifted to their social contacts and to some vocation. 
Hobbies and non-~unctional o~o11patinna1 therapy are. 
undesireable since they fttrnish no opp.ortuni ty for nex-
presaing aggression" btlt rather accentuate the rt:feeling of 
di ffe1rence .n 
Observations have sho\vn that situations involving 
criticism or competition or sense of cuilt may frequently 
-/~ cause exacerbations of the disease. 
a 
0 
Therefore, Dunbar feels that these child:r•en shou.ld. 
be handled in sr·e6ial classes at school and in special 
inati tu.tions where psyahotheraj;y is of;fered and where they 
are trained in a ttseful occupation • 
. 
In V'ie\v of the conflict preoent in rheurnstio subject, 
aoo~rding to theotheory, the F.aJor need is the relief of 
the guilt feelings related to their semual'dif£iculties~ 
However, tt1is guilt is thoUght to be so de~.P reaching and 
so likoly ·bo be expressed son~atically, that it is necessary 
•,.o establish some sense of security before attempting to 
aid them with this problem~ 
"In all oasos. • • brief psyahotherapy should be based 
on dynamic principles with an attempt to strengthen the ego 
~~ 
as well as to resolvetli~e anxiety relative to their am-
.,\· -.( 
... 
bigu.ous sexual role~ n 106 ~ 
-
It is impossible to draw any valid conclusions from 
the limited :,,ork \'7hich has been done up to the present 
ti~e in the field of psychotherapy in rheumatic fever. 
It will be interesti4g to see vmat the rapidy expanding 
field of psyahosorratic medicine \Vill be able to offer 
fu.tu.:re generations as far as treatment end prevention 
of rheumatic fever. is conoe~ned; 
a 
0 
SUMMARY 
.;:. 
When a patient is sean during an acnte attack of 
rheumatic fever, complete bed rest is essential. A well-
balanced diet should be administered. ,Saliaylates are 
effective analgesic and antipyretic agents, but a specific 
anti~rheumatic action of these drugs ~s doubtful, These 
drugs should be administered orally in large doses until 
the blood sedimentation rate has fallen.to nearly normal 
levels. The toxic ~nifestations of these drugs have be~n 
· discussed in detail. since it is necessary for the phy-
sician to be acquainted with those symptoms which are to 
be expected* and those Which call for immediate cessation 
of treatment. Fever therapy gives excellent results in 
treatment of patients whose rheumatic manifestations are 
in the ~orm of chorea. In the raDe patient in whom acute 
carditis progresses to heart failure, digitalis, diuretic 
agents and oxygen are indicated. 
Once the rati~nt has b~en carried through the 
acnte phase of the disease, sulfonamide prophylaxis seems 
indicated throughout the year over a period of several 
years in or~er·to vrevent streptooocoal in~eations wbioh 
usually precede recurrent attacks. The recent appearance 
of sulfonamide-resistant beta-hemolytic streptococci may 
necessitate altering our concepts of prophylaxis. Oral 
penicillin may prove a usef~l prophylactic drug. However, 
0 
. 
the sulfonamides and penicillin are contraindicated in the 
aQute phase of the disease. Tons~llectomy should be 
performed only when there.is evidence of a long-standing 
chronic focus of infection leading to tr~quent sore throats, 
eto. Removal of tonsils, when necessary,· should be dpne 
only during t~e quiescent stage of the disease. Salicylate 
prophylaxis.may be harmful in that the symptpms of an 
acute exacerbation of the disease may be masked, ·and that 
activity duri!l..g su~h an attaolt may lead to. irreversible 
catdiac damage. Immunization therapy .is pr.omising .• but no 
reoent work has been done with it~ . 
The desirability of a warm dry climate with stable 
barometric pressure has been mentioned as a valuable method 
of re'ducing the rate of recurrences. The inoidenc.e of 
rheurratio fever among the lower economic classes has been 
associated with a possible de~ioiency in certain dietary 
faa tors, especial.ly culcium and ".rotein, and possibly 
several vitamins. 
Throughout the paper, the lack of definite 
knowledge concerning the etiology of rheumatic fever has 
been stressed. Whe~ the etiological factor is de~initely 
established, our concepts of treatment and prophylaxis 
7 
may all become obsolete. It is possible that the psycho- c~· 
som$tio approach to the problem of rhoumatio·intection 
may prove fruitful. At any rate, we can conclude that 
our present day methods of therapy, even when empl·oY:ed 
together properly have not given us the answer ~or which 
we have oeen seeking----the method ot·prevention of· 
Rheumatic Heart D~sease. The im:portan~e of devoting 
. . 
adequate tirre to study the unsolved problems in the 
' ' t~eatment of Rheumatic Fever oannot be overemphasized 
in view of the prevalence ~nd permanence of the s,equelae 
ot this infection. 
0 
0 
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